<SEC-DOCUMENT>0001493152-22-012822.txt : 20220511
<SEC-HEADER>0001493152-22-012822.hdr.sgml : 20220511
<ACCEPTANCE-DATETIME>20220511134650
ACCESSION NUMBER:		0001493152-22-012822
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220505
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220511
DATE AS OF CHANGE:		20220511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enveric Biosciences, Inc.
		CENTRAL INDEX KEY:			0000890821
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				954484725
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38286
		FILM NUMBER:		22913076

	BUSINESS ADDRESS:	
		STREET 1:		4851 TAMIAMI TRAIL N, SUITE 200
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34103
		BUSINESS PHONE:		239-302-1707

	MAIL ADDRESS:	
		STREET 1:		4851 TAMIAMI TRAIL N, SUITE 200
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERI Holdings, Inc.
		DATE OF NAME CHANGE:	20150527

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SPATIALIZER AUDIO LABORATORIES INC
		DATE OF NAME CHANGE:	19950323
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ENVB="http://enveric.com/20220505">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_ENVB_enveric.com_20220505 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20220505_20220505 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0000890821 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityCentralIndexKey">0000890821</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="envb-20220505.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-05-05to2022-05-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000890821</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-05</xbrli:startDate>
        <xbrli:endDate>2022-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20220505__20220505_zToqDuYgFhM5"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_90C_edei--DocumentPeriodEndDate_c20220505__20220505_zYBS4jKgv5qj"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 5, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20220505__20220505_zPPmRjBPe6V8"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityRegistrantName">Enveric
Biosciences, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of Registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20220505__20220505_zdtQNvNqDqba"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20220505__20220505_zlLaEM1a2MUf"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityFileNumber">001-38286</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20220505__20220505_zw05xKw5rx7g"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityTaxIdentificationNumber">95-4484725</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    No.)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Enveric
Biosciences, <span>Inc.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_908_edei--EntityAddressAddressLine1_c20220505__20220505_z1XZxJOyJ5Eb"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityAddressAddressLine1">4851
Tamiami Trail N</ix:nonNumeric></span></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20220505__20220505_zv3izzMcUskg"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20220505__20220505_z8ZDNvhjtw45"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityAddressCityOrTown">Naples</ix:nonNumeric></span>,
<span id="xdx_90B_edei--EntityAddressStateOrProvince_c20220505__20220505_zExlrcrSBXK"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20220505__20220505_z42Pgm2TwCtl"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:EntityAddressPostalZipCode">34103</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of principal executive offices and zip code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code: <span id="xdx_907_edei--CityAreaCode_c20220505__20220505_zruEyTMDdIV1"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:CityAreaCode">(239)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20220505__20220505_zmsS7k5g0fI"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:LocalPhoneNumber">302-1707</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20220505__20220505_z1SzfChnZ2tf"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20220505__20220505_zN0fAjDNAYo3"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20220505__20220505_zChpsxUvm0Hg"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20220505__20220505_z7Z9K24n9mS7"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20220505__20220505_zG2ax6hKl0Y5"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:Security12bTitle">Common stock, par value
    $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20220505__20220505_zdYsEMOQMzBk"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" name="dei:TradingSymbol">ENVB</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20220505__20220505_zImQgwpgRGjc"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20220505__20220505_zR71w8VpNhub"><ix:nonNumeric contextRef="From2022-05-05to2022-05-05" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry Into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Enveric Biosciences, Inc.&#8217;s (the &#8220;<b><i>Company</i></b>&#8221;) planned spin off its cannabinoid assets into
a separately traded public company, the Company created Acanna Therapeutics, Inc. (&#8220;<b><i>Acanna</i></b>&#8221;), a wholly-owned
subsidiary of the Company, and, on May 5, 2022, Acanna and the Company entered into a Securities Purchase Agreement (the &#8220;<b><i>Purchase
Agreement</i></b>&#8221;) with an accredited investor (the &#8220;<b><i>Investor</i></b>&#8221;), pursuant to which Acanna agreed to
sell up to an aggregate of 5,000 shares of Acanna&#8217;s Series A Convertible Preferred Stock, par value $0.01 per share (the &#8220;<b><i>Series
A Preferred Stock</i></b>&#8221;), at price of $1,000 per share, and warrants (the &#8220;<b><i>Warrants</i></b>&#8221;) to purchase
shares of Acanna&#8217;s common stock, par value $0.01 per share (the &#8220;<b><i>Acanna Common Stock</i></b>&#8221;), for an aggregate
purchase price of up to $5,000,000 (the &#8220;<b><i>Private Placement</i></b>&#8221;). Pursuant to the Purchase Agreement, Acanna has
issued 1,000 shares of the Series A Preferred Stock to the Investor in exchange for $1,000,000 on May 5, 2022, with the remaining Series
A Preferred Stock and Warrants to be issued for a price of $4,000,000 upon the completion of the spin-off of Acanna into an independent,
separately traded public company listed on The Nasdaq Stock Market (the &#8220;<b><i>Spin-Off</i></b>&#8221; and such date that Acanna
commences trading on the Nasdaq Stock Market being referred to herein as the &#8220;<b><i>Spin-Off Date</i></b>&#8221;). Pursuant the
terms of the Purchase Agreement and the Certificate of the Designations (as defined below), the holders of the Series A Preferred Stock
have a Put Right (as defined below) under certain circumstances described below, with Acanna&#8217;s payment obligations under the Put
Right guaranteed by the Company. The Purchase Agreement contains customary representations and warranties, agreements, obligations, conditions
to closing and termination provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium
Capital Advisors, LLC (&#8220;<b><i>Palladium</i></b>&#8221;) acted as placement agent for the Private Placement. Pursuant to the Purchase
Agreement, Acanna has agreed to pay Palladium a cash fee equal to 9% of the aggregate gross proceeds raised from the sale of the shares
of the Series A Preferred Stock and a non-accountable expense allowance of 1% of the aggregate gross proceeds raised the sale of the
Series A Preferred Stock in the Private Placement. In addition, Acanna will issue to Palladium warrants equal to 8% of the shares issuable
upon conversion of the Series A Preferred Stock (the &#8220;<b><i>Palladium Warrants</i></b>&#8221;). The fee due in connection with
the Private Placement shall be paid to Palladium in the form of convertible preferred stock and warrants on similar terms to the securities
issued in the Private Placement (together with the Palladium Warrants, the &#8220;<b><i>Palladium Securities</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Terms
of Series A Preferred Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of the Designations, Preferences and Rights of Series A Convertible Preferred Stock (the &#8220;<b><i>Certificate of
Designations</i></b>&#8221;), on or immediately prior to the Spin-Off Date, each share of SeriesA Preferred Stock will be automatically
converted into a number of shares of Acanna Common Stock equal to 25% of the then issued and outstanding Acanna Common Stock, subject
to the Beneficial Ownership Limitation (as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Designations contains limitations that prevent the holder thereof from acquiring shares of Acanna Common Stock upon conversion
that would result in the number of shares of Acanna Common Stock beneficially owned by such holder and its affiliates exceeding 9.99%
of the total number of shares of Acanna Common Stock outstanding immediately after giving effect to the conversion (the &#8220;<b><i>Beneficial
Ownership Limitation</i></b>&#8221;), except that upon notice from the holder to Acanna, the holder may increase or decrease the amount
of ownership of outstanding shares of Acanna Common Stock after converting the holder&#8217;s shares of Series A Preferred Stock, provided
that any change in the Beneficial Ownership Limitation shall not be effective until 61 days following notice to Acanna.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Designations provides that upon the earlier of (i) the one-year anniversary of May 5, 2022, and only in the event that
the Spin-Off has not occurred; or (ii) such time that Acanna and the Company have abandoned the Spin-Off or the Company is no longer
pursuing the Spin-Off in good faith, the holders of the Series A Preferred Stock shall have the right (the &#8220;<b><i>Put Right</i></b>&#8221;),
but not the obligation, to cause Acanna to purchase all or a portion of the Series A Preferred Stock for a purchase price equal to $1,000
per share, subject to certain adjustments (the &#8220;<b><i>Stated Value</i></b>&#8221;), plus all the accrued but unpaid dividends per
share. In addition,  after the one-year anniversary of May 5, 2022, and only in the event that the Spin-Off has not occurred and Acanna
is not in material default of any of the transaction documents, Acanna may, at its option, at any time and from time to time, redeem
the outstanding shares of Series A Preferred Stock, in whole or in part, for a purchase price equal to the aggregate Stated Value of
the shares of Series A Preferred Stock being redeemed and the accrued and unpaid dividends on such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, Acanna entered into a registration rights agreement, dated as of May 5, 2022 (the &#8220;<b><i>Registration
Rights Agreement</i></b>&#8221;), with the Investor, pursuant to which Acanna shall, on such date that Acanna files a registration statement
with the Securities and Exchange Commission in connection with the Spin-Off, file such a registration statement to register the shares
of Acanna Common Stock issuable upon: (i) the conversion of the Series <span style="text-transform: uppercase">A </span>Preferred Stock
sold in the Private Placement, (ii) the exercise of the Warrants sold in the Private Placement, and (iii) the conversion or exercise,
as applicable, of the Palladium Securities (the &#8220;<b><i>Registrable Securities</i></b>&#8221;); and to cause such registration statement
to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the
Spin-Off Date, and shall use its reasonable best efforts to keep such registration statement continuously effective under the Securities
Act until the date that all Registrable Securities covered by such registration statement have been sold or are otherwise able to be
sold pursuant to Rule 144. The Registration Rights Agreement provides for liquidated damages to the extent that Acanna does not file
or maintain a registration statement in accordance with the terms thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Purchase Agreement, Certificate of Designations, Registration Rights Agreement and Warrants
are qualified in their entirety by reference to the Purchase Agreement, Certificate of Designations, Registration Rights Agreement
and Warrants, which are attached hereto as Exhibit 10.1, Exhibit 10.2, Exhibit 10.3 and Exhibit 10.4, respectively,
and incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2022, the Company issued a press release, attached hereto as Exhibit 99.1, announcing the Company&#8217;s intention to pursue
the Spin-Off. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &#8220;<b><i>Exchange Act</i></b>&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by
reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended
to constitute a determination by the Company that the information contained herein, including the exhibit hereto, is material or that
the dissemination of such information is required by Regulation FD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of the Designations, Preferences and Rights of Series A Convertible Preferred Stock</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, issued May 11, 2022 (furnished pursuant to Item 7.01)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the
    Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* *</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>ENVERIC BIOSCIENCES,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May 11, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Joseph Tucker</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Tucker</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2Wsq1uvGupCSyCInodskxlnRHZrcfH6m3bFWiYWAYzvnOESIUGW10jQyXVZHDCZu2Vg6hwAoZzRW9I93uEvC3wJu2jpVxw/sDU/IMemYxkTPlhcH61BbLBKLFVMppHEM0T+QclnsR9HpKptIlGqdVDcqUcGRqWaNT3I0JJ/UmQ003VJ2RrSaTgJxEo/yBOJIxHOipXsR3C3meiiAcJhAZ06Ptax7WUQPrGhvfZUf0v8EXDGxJNQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITIES PURCHASE AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), is entered into as of [__], 2022 (the &ldquo;<U>Execution Date</U>&rdquo;),
by and among Acanna Therapeutics, Inc., a Delaware corporation, with headquarters located at 4851 Tamiami Trail N, Suite 200, Naples,
FL 34103 (the &ldquo;<U>Company</U>&rdquo; or &ldquo;<U>SpinCo</U>&rdquo;), and the investors listed on the <U>Schedule of Buyers</U>
attached hereto (individually, a &ldquo;<U>Buyer</U>&rdquo; and collectively, the &ldquo;<U>Buyers</U>&rdquo;) and soley in connection
with <U>Sections 1(b)</U>, <U>4(b)</U>, <U>4(d), 4(g)</U> , <U>4</U>(<U>q</U>) and <U>9</U>, Enveric Biosciences, Inc., a Delaware corporation
(&ldquo;<U>Enveric</U>&rdquo; or &ldquo;<U>Parent</U>&rdquo;) and the parent company of SpinCo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
WHEREAS, the Company and each Buyer is executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<U>1933 Act</U>&rdquo;), and Rule 506(b) of Regulation
D (&ldquo;<U>Regulation D</U>&rdquo;) as promulgated by the United States Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;)
under the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
WHEREAS, the Company has authorized a new series of convertible preferred stock of the Company designated as Series A Convertible Preferred
Stock (the &ldquo;<U>Series A Preferred Stock</U>&rdquo;), the terms of which are set forth in the certificate of designation for such
series of preferred stock (the &ldquo;<U>Certificate of Designations</U>&rdquo;) in the form attached hereto as <U>Exhibit A</U> (together
with any convertible preferred stock issued in replacement thereof in accordance with the terms thereof, the &ldquo;<U>Preferred Shares</U>&rdquo;),
which Preferred Shares shall be convertible into the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;),
in accordance with the terms of the Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
WHEREAS, each Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, (i) that
aggregate number of Preferred Shares set forth opposite such Buyer&rsquo;s name in column (8) (the &ldquo;<U>Preferred Shares Subscription
Amount</U>&rdquo;) on the <U>Schedule of Buyers</U> (which aggregate number for all Buyers shall be 5,000, and (ii) Warrants, in substantially
the forms attached hereto as <U>Exhibit B</U> (the &ldquo;<U>Warrants</U>&rdquo;), representing the right to acquire that number of shares
of Common Stock as set forth opposite such Buyer&rsquo;s name in column (6) on the <U>Schedule of Buyers</U> (as exercised, collectively,
the &ldquo;<U>Warrant Shares</U>&rdquo;). The shares of Common Stock issuable pursuant to the terms of the Preferred Shares are referred
to herein as the &ldquo;<U>Conversion Shares</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
WHEREAS, the Preferred Shares, the Warrants, the Conversion Shares and the Warrant Shares are collectively referred to herein as the
&ldquo;<U>Securities</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing premises, and the promises and covenants herein contained, the receipt and sufficiency of
which are hereby acknowledged by the parties hereto, the Company and each Buyer (severally and not jointly), intending to be legally
bound, hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B>PURCHASE AND SALE OF PREFERRED SHARES AND WARRANTS; SPIN-OFF</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Closings.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Preferred Shares and Warrants</U>. Subject to the satisfaction (or waiver) of the conditions set forth in <U>Sections 6</U> and <U>7
</U>below, the Company agrees to issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase from the
Company (x) on the Initial Closing Date (as defined below), the number of Preferred Shares, as is set forth opposite such Buyer&rsquo;s
name in column (3) on the <U>Schedule of Buyers</U>, up to an aggregate amount of $1,000,000.00 for all Buyers (the &ldquo;<U>Initial
Closing</U>&rdquo;) and (y) on the Final Closing Date (as defined below) (A) the number of Preferred Shares, as is set forth opposite
such Buyer&rsquo;s name in column (5) on the <U>Schedule of Buyers</U> and (B) Warrants to acquire up to that number of Warrant Shares
as is set forth opposite such Buyer&rsquo;s name in column (6) on the <U>Schedule of Buyers</U> up to an aggregate amount of $4,000,000.00
for all Buyers (the &ldquo;<U>Final Closing</U>&rdquo; and together with the Initial Closing, the &ldquo;<U>Closings</U>&rdquo; and each
a &ldquo;<U>Closing</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Initial Closing</U>. The date and time of the Initial Closing (the &ldquo;<U>Initial Closing Date</U>&rdquo;) shall be 10:00 a.m.,
New York City time, on the Execution Date (or such later date as is mutually agreed to by the Company and each Buyer) after notification
of satisfaction (or waiver) of the conditions to the Closing set forth in <U>Sections 6</U> and <U>7</U> below, at the offices of Haynes
and Boone, LLP, 30 Rockefeller Plaza 26th floor, New York, NY 10112 or such other location agreed to by the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Final Closing</U>. The date and time of the Final Closing (the &ldquo;<U>Final Closing Date</U>&rdquo; and together with the Initial
Closing Date, the &ldquo;<U>Closing Dates</U>&rdquo; and each a &ldquo;<U>Closing Date</U>&rdquo;) shall be on or immediately prior to
the consummation of the Spin-Off Date (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Purchase Price</U>. The aggregate purchase price for the Preferred Shares to be purchased by each Buyer (the &ldquo;<U>Purchase Price</U>&rdquo;)
shall be the amount set forth opposite such Buyer&rsquo;s name in Column (9) on the <U>Schedule of Buyers</U> up to an aggregate amount
of $5,000,000.00 for all Buyers. Each Buyer shall pay $1,000 for each Preferred Share to be purchased by such Buyer at the Initial Closing.
Each Buyer shall pay $1,000 for each Preferred Share and related Warrants to be purchased by such Buyer at the Final Closing (the &ldquo;<U>Unit
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Form of Payment</U>. On each Closing Date, (A) each Buyer shall deliver to the Company, its portion of the Purchase Price to the Company
for the Preferred Shares and Warrants, as applicable, to be issued and sold to such Buyer at the applicable Closing (less, in the case
of any Buyer the amount withheld by such Buyer pursuant to <U>Section 4(e)</U>), by wire transfer of immediately available funds in accordance
with the Company&rsquo;s written wire instructions and (B) the Company shall deliver to each Buyer the Preferred Shares and related Warrants,
as applicable, which such Buyer is purchasing hereunder, in each case duly executed on behalf of the Company and registered in the name
of such Buyer or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Spin-Off</U>. Enveric has undertaken the spin-off of the Company such that it is in the process of being separated from the existing
business of Enveric through a series of transactions (the &ldquo;<U>Spin-Off</U>&rdquo;) that, when completed in its entirety, will result
in the Company becoming an independent, separately traded public company listed on the NASDAQ, with such date that SpinCo commences trading
on the NASDAQ as a separate public company from Enveric being referred to herein as the &ldquo;<U>Spin-Off Date</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B>BUYER&rsquo;S REPRESENTATIONS AND WARRANTIES</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Buyer, severally and not jointly, represents and warrants with respect to only itself, as of the Execution Date and as of each Closing
Date, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents (as defined in <U>Section 3b</U> below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Public Sale or Distribution</U>. Such Buyer is (i) acquiring the Preferred Shares and the Warrants, (ii) upon conversion of the
Preferred Shares will acquire the Conversion Shares and (iii) upon exercise of the Warrants will acquire the Warrant Shares issuable
upon exercise of the Warrants, in each case, for its own account and not with a view towards, or for resale in connection with, the public
sale or distribution thereof, except pursuant to sales registered or exempted under the 1933 Act; provided, however, that by making the
representations herein, such Buyer does not agree to hold any of the Securities for any minimum or other specific term and reserves the
right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the 1933
Act. Such Buyer is acquiring the Securities hereunder in the ordinary course of its business. Such Buyer does not presently have any
agreement or understanding, directly or indirectly, with any Person (as defined below) to distribute any of the Securities. For purposes
of this Agreement, &ldquo;<U>Person</U>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization and a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Accredited Investor Status</U>. Such Buyer is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation
D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Reliance on Exemptions</U>. Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and such Buyer&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of such Buyer to acquire
the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Information</U>. Such Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances and
operations of the Company and materials relating to the offer and sale of the Securities that have been requested by such Buyer in writing.
Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor any
other due diligence investigations conducted by such Buyer or its advisors, if any, or its representatives shall modify, amend or affect
such Buyer&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained herein. Such Buyer understands that
its investment in the Securities involves a high degree of risk. Such Buyer has sought such accounting, legal and tax advice as it has
considered necessary to make an informed investment decision with respect to its acquisition of the Securities.</FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>No Governmental Review</U>. Such Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in
the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Transfer or Resale</U>. Such Buyer understands that except as provided for in the Transaction Documents: (i) the Securities have not
been and are not being registered under the 1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or
transferred unless (A) subsequently registered thereunder, (B) with respect to the Preferred Shares and the Warrants such Buyer shall
have delivered to the Company an opinion of counsel, in a generally acceptable form, to the effect that such Securities to be sold, assigned
or transferred may be sold, assigned or transferred pursuant to an exemption from such registration (any which such opinion the Company
expressly agrees to reimburse the Buyer&rsquo;s expenses for), or (C) such Buyer provides the Company with reasonable assurance that
such Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act, as amended, (or
a successor rule thereto) (collectively, &ldquo;<U>Rule 144</U>&rdquo;); (ii) any sale of the Securities made in reliance on Rule 144
may be made only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the Securities under
circumstances in which the seller (or the Person) through whom the sale is made) may be deemed to be an underwriter (as that term is
defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC
thereunder; and (iii) neither the Company nor any other Person is under any obligation to register the Securities under the 1933 Act
or any state securities laws or to comply with the terms and conditions of any exemption thereunder. Notwithstanding the foregoing, the
Securities may be pledged in connection with a bona fide margin account or other loan or financing arrangement secured by the Securities
and such pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder, and no Buyer effecting
a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any delivery to the Company
pursuant to this Agreement or any other Transaction Document (as defined in <U>Section 3(b)</U>), including, without limitation, this
<U>Section 2(g)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Legends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Such Buyer understands that the certificates or other instruments representing the Preferred Shares and the Warrants, until such time
as the resale of the Conversion Shares and the Warrant Shares have been registered under the 1933 Act, the stock certificates representing
the Conversion Shares and the Warrant Shares, except as set forth below, shall bear a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of such stock certificates):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE][EXERCISABLE]
HAVE BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A)
AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER
SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR
FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time after the Execution Date, the legend set forth above shall be removed and the Company shall issue a certificate without such
legend to the holder of the Securities upon which it is stamped or, if available, issue to such holder by electronic delivery at the
applicable balance account at The Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;), if (i) such Securities are registered for resale
under the 1933 Act, (ii) in connection with a sale, assignment or other transfer (other than pursuant to Rule 144), such holder provides
the Company with an opinion of counsel, in a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities
may be made without registration under the applicable requirements of the 1933 Act, or (iii) the Securities can be sold, assigned or
transferred pursuant to Rule 144 or Rule 144A without the need to comply with public information requirements or volume limitations.
The Company shall be responsible for the fees of its transfer agent, legal counsel (including, without limitation, with respect to any
legal opinion upon any sale pursuant to Rule 144) and all DTC fees associated with such issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates
evidencing the Conversion Shares or Warrants Shares (collectively the &ldquo;<U>Underlying Shares</U>&rdquo;) shall not contain any legend
(&ldquo;<U>Unlegended Shares</U>&rdquo;) (including the legends set forth in Section 2(h) hereof): (i) while a registration statement
covering the resale of such security is effective under the Securities Act, (ii) if such Underlying Shares are eligible for sale under
Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as
to such Underlying Shares and without volume or manner-of-sale restrictions, or (iii) if such legend is not required under applicable
requirements of the Securities Act. The Company agrees that following such time as all such legends are no longer required under this
Section, it will, no later than five (5) Trading Days (as defined in the Certificate of Designations) following the delivery by such
Buyer to the Company or the Transfer Agent of a certificate representing Underlying Shares, as applicable, issued with a restrictive
legend (such fifth Trading Day, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Buyer a certificate
representing such shares that is free from all restrictive and other legends (however, the Company shall use reasonable best efforts
to deliver such shares within two (2) Trading Days). The Company may not make any notation on its records or give instructions to the
Transfer Agent that enlarge the restrictions on transfer set forth in this Section. Certificates for Underlying Shares subject to legend
removal hereunder shall, if possible, be transmitted by the Transfer Agent to such Buyer by crediting the account of such Buyer&rsquo;s
prime broker with the Depository Trust Company System as directed by such Buyer.In addition to such Buyer&rsquo;s other available remedies,
the Company shall pay to a Buyer, in cash, as partial liquidated damages and not as a penalty, for each $1,000 of Underlying Shares (based
on the highest of the actual purchase price or VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent)
delivered for removal of the restrictive legend and subject to Section 4.1(d), $10 per Trading Day for each Trading Day after the Legend
Removal Date (increasing to $20 per Trading Day after the fifth Trading Day) until such certificate is delivered without a legend. Nothing
herein shall limit such Buyer&rsquo;s right to pursue actual damages for the Company&rsquo;s failure to deliver certificates representing
any Securities as required by the Transaction Documents, and such Buyer shall have the right to pursue all remedies available to it at
law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Validity; Enforcement</U>. This Agreement and the other Transaction Documents to which such Buyer is a party have been duly and validly
authorized, executed and delivered on behalf of such Buyer and shall constitute the legal, valid and binding obligations of such Buyer
enforceable against such Buyer in accordance with their respective terms, except as such enforceability may be limited by general principles
of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting
generally, the enforcement of applicable creditors&rsquo; rights and remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>No Conflicts</U>. The execution, delivery and performance by such Buyer of this Agreement and the other Transaction Documents to which
such Buyer is a party and the consummation by such Buyer of the transactions contemplated hereby and thereby will not (i) result in a
violation of the organizational documents of such Buyer or (ii) conflict with, or constitute a default (or an event which with notice
or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws) applicable to such Buyer, except in the case of clauses (ii)
and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the aggregate, reasonably be
expected to have a material adverse effect on the ability of such Buyer to perform its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the disclosure schedules, which disclosure schedules shall be deemed a part hereof and shall qualify any representation
or otherwise made herein to the extent of the disclosure contained in the corresponding section of the disclosure schedules, the Company
represents and warrants to each of the Buyers that, as of the Execution Date and as of each Closing Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization and Qualification</U>. Each of the Company and its &ldquo;<U>Subsidiaries</U>&rdquo; (which for purposes of this Agreement
means any joint venture or any entity in which the Company, directly or indirectly, owns more than 10% of the capital stock or holds
an equivalent equity or similar interest) are entities duly organized and validly existing and in good standing under the laws of the
jurisdiction in which they are formed, and have the requisite power and authorization to own their properties and to carry on their business
as now being conducted. Each of the Company and its Subsidiaries is duly qualified as a foreign entity to do business and is in good
standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a
Material Adverse Effect. As used in this Agreement, &ldquo;<U>Material Adverse Effect</U>&rdquo; means any material adverse effect on
the business, properties, assets, operations, results of operations or condition (financial or otherwise) of the Company and its Subsidiaries,
individually or taken as a whole, or on the transactions contemplated hereby or in the other Transaction Documents or by the agreements
and instruments to be entered into in connection herewith or therewith, or on the authority or ability of the Company to perform its
obligations under the Transaction Documents. As used in this Agreement, any adverse event that does not have a long-term effect on the
Company is not a Material Adverse Effect. For purposes of this subsection, &ldquo;long-term effect&rdquo; means an effect lasting more
than one (1) year. Reasonably promptly after the date of this Agreement, and in any event no later than prior to the Spin-off, Parent
will will assign to the Company all the assets necessary for SpinCo to conduct its intended business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Authorization; Enforcement; Validity</U>. The Company has the requisite corporate power and authority to enter into and perform its
obligations under this Agreement, the Certificate of Designations, the Warrants, the RRA, and each of the other agreements entered into
by the parties hereto in connection with the transactions contemplated by this Agreement (collectively, the &ldquo;<U>Transaction Documents</U>&rdquo;)
and to issue the Securities in accordance with the terms hereof and thereof. The execution and delivery of the Transaction Documents
by the Company and the consummation by the Company of the transactions contemplated hereby and thereby, including, without limitation,
the issuance of the Preferred Shares and Warrants and the reservation for issuance and the issuance of the Conversion Shares issuable
upon conversion of the Preferred Shares and the reservation for issuance and issuance of Warrant Shares issuable upon exercise of the
Warrants have been duly authorized by the Company&rsquo;s Board of Directors and no further filing, consent, or authorization is required
by the Company, its board of directors or its stockholders, except for any authorizations or consents that have already been obtained.
This Agreement and the other Transaction Documents of even date herewith have been duly executed and delivered by the Company, and constitute
the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except
as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo; rights and remedies.
The Certificate of Designations in the form attached hereto as <U>Exhibit A</U> has been filed with the Secretary of State of the State
of Delaware and is in full force and effect, enforceable against the Company in accordance with its terms and has not been amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Issuance of Securities</U>. The issuance of the Preferred Shares and the Warrants have been duly authorized and upon issuance in accordance
with the terms of the Transaction Documents shall be validly issued, fully paid, non-assessable and free from all preemptive rights,
taxes, liens and charges with respect to the issue thereof, and the Preferred Shares shall be entitled to the rights and preferences
set forth in the Certificate of Designations. As of the Initial Closing, the Company shall have reserved from its duly authorized capital
stock not less than the sum of 100% of the maximum number of shares of Common Stock issuable (i) upon conversion of the maximum number
of Preferred Shares (assuming for purposes hereof, that the Preferred Shares are convertible at the Conversion Price (as defined in the
Certificate of Designations) and without taking into account any limitations on the conversion of the Preferred Shares set forth in the
Certificate of Designations) and (ii) upon exercise of the Warrants (without taking into account any limitations on the exercise of the
Warrants set forth in the Warrants), in each case, determined as if issued as of the Trading Day immediately preceding the applicable
date of determination. Upon issuance or conversion in accordance with the Certificate of Designations or the exercise of the Warrants
and payment of the exercise price under the Warrants thereunder, the Conversion Shares and the Warrant Shares, respectively, will be
validly issued, fully paid and nonassessable and free from all preemptive or similar rights, taxes, liens and charges with respect to
the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. Assuming the accuracy of each
of the representations and warranties set forth in <U>Section 2</U> of this Agreement, the offer and issuance by the Company of the Securities
is exempt from registration under the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Preferred Shares and
the Warrants, and reservation for issuance and issuance of the Conversion Shares and the Warrant Shares) will not (i) result in a violation
of any certificate of incorporation, any certificate of formation, any certificate of designations or other constituent documents of
the Company or any of its Subsidiaries, any capital stock of the Company or any of its Subsidiaries or the bylaws of the Company or any
of its Subsidiaries or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become
a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule,
regulation, order, judgment or decree (including foreign, federal and state laws and regulations) applicable to the Company or any of
its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Consents</U>. Neither the Company nor any of its Subsidiaries is required to obtain any consent, authorization or order of, or make
any filing or registration with, any government, court, regulatory, self-regulatory, administrative agency or commission or other governmental
agency, authority or instrumentality, domestic or foreign, of competent jurisdiction (a &ldquo;<U>Governmental Authority</U>&rdquo;)
or any other Person in order for it to execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents,
in each case in accordance with the terms hereof or thereof, except for (i) the filing of the Certificate of Designations with the Secretary
of State of the State of Delaware, (ii) the filing of a Form D pursuant to Regulation D promulgated by the SEC under the 1933 Act, (iii)
the filings required by applicable state &ldquo;blue sky&rdquo; securities laws, rules and regulations, and (iv) the Registration Statement.
The Company and its Subsidiaries are unaware of any facts or circumstances that might prevent the Company from obtaining or effecting
any of the registration, application or filings pursuant to the preceding sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Acknowledgment Regarding Buyer&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees that each Buyer is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby
and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, or (ii) an &ldquo;affiliate&rdquo;
(as defined in Rule 144) of the Company or any of its Subsidiaries. The Company further acknowledges that no Buyer is acting as a financial
advisor or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents
and the transactions contemplated hereby and thereby, and any advice given by a Buyer or any of its representatives or agents in connection
with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to such Buyer&rsquo;s purchase
of the Securities. The Company further represents to each Buyer that the Company&rsquo;s decision to enter into the Transaction Documents
has been based solely on the independent evaluation by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>No General Solicitation; Placement Agent</U>. Neither the Company, nor any of its Subsidiaries or affiliates, nor any Person acting
on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in
connection with the offer or sale of the Securities. The Company shall be responsible for the payment of any placement agent&rsquo;s
fees, financial advisory fees, or brokers&rsquo; commissions (other than for Persons engaged by any Buyer or its investment advisor)
relating to or arising out of the transactions contemplated hereby, including, without limitation, placement agent fees payable to Palladium
Capital Group, LLC, as sole placement agent (the &ldquo;<U>Placement Agent</U>&rdquo;) in connection with the sale of the Securities.
The fees and expenses of the Placement Agent to be paid by the Company or any of its Subsidiaries are as set forth on Schedule 3(g) attached
hereto. The Company shall pay, and hold each Buyer harmless against, any liability, loss or expense (including, without limitation, attorney&rsquo;s
fees and out-of-pocket expenses) arising in connection with any such claim. The Company acknowledges that it has engaged the Placement
Agent in connection with the sale of the Securities and to serve as the financial advisor to the parties in connection with the Spin-Off.
Other than the Placement Agent, neither the Company nor any of its Subsidiaries has engaged any placement agent or other agent in connection
with the offer or sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Integrated Offering</U>. None of the Company, its Subsidiaries, any of their affiliates, and any Person acting on their behalf
has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would require registration of any of the Securities under the 1933 Act, whether through integration with prior offerings or otherwise,
or caused this offering of the Securities to require approval of stockholders of the Company for purposes of any applicable stockholder
approval provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on
which any of the securities of the Company are listed or designated, but excluding stockholder consents required to authorize and issue
the Securities or waive any anti-dilution provisions in connection therewith. None of the Company, its Subsidiaries, their affiliates
and any Person acting on their behalf will take any action or steps referred to in the preceding sentence that would require registration
of any of the Securities under the 1933 Act or cause the offering of the Securities to be integrated with other offerings for purposes
of any such applicable stockholder approval provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Dilutive Effect</U>. The Company understands and acknowledges that the number of Conversion Shares issuable upon conversion of the
Preferred Shares will increase in certain circumstances. The Company further acknowledges that its obligation to issue Conversion Shares
upon conversion of the Preferred Shares in accordance with this Agreement and the Certificate of Designations, and its obligation to
issue the Warrant Shares upon exercise of the Warrants in accordance with this Agreement and the Warrants, is, in each case, not limited
by the dilutive effect that such issuance may have on the ownership interests of other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Application of Takeover Protections; Rights Agreement</U>. The Company and its board of directors have taken all necessary action,
if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s Certificate of Incorporation, any certificates
of designations or the laws of the jurisdiction of its formation or incorporation which is or could become applicable to any Buyer as
a result of the transactions contemplated by this Agreement, including, without limitation, the Company&rsquo;s issuance of the Securities
and any Buyer&rsquo;s ownership of the Securities. The Company and its board of directors have taken all necessary actions, if any, in
order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership of
Common Stock or a change in control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Conduct of Business; Regulatory Permits</U>. Neither the Company nor any of its Subsidiaries is in violation of any term of or in
default under its Certificate of Incorporation, the Certificate of Designations, any other certificate of designation, preferences or
rights of any other outstanding series of preferred stock of the Company or the Company&rsquo;s Bylaws or their organizational charter
or Certificate of Incorporation or bylaws, respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment,
decree or order or any statute, ordinance, rule or regulation (each a &ldquo;<U>Legal Requirement</U>&rdquo;) applicable to the Company
or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct its business in violation of any of the
foregoing, except for possible violations which could not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. The Company and its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory
authorities necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or
permits would not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary
has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit. There
is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the
Company or any of its Subsidiaries is a party which has or could reasonably be expected to have the effect of prohibiting or materially
impairing any business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries
or the conduct of business by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or
in the aggregate, which have not had and could not reasonably be expected to have a Material Adverse Effect on the Company or any of
its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any of its Subsidiaries nor any director, officer, agent, employee or other
Person acting on behalf of the Company or any of its Subsidiaries has, in the course of its actions for, or on behalf of, the Company
or any of its Subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses
relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee
from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended;
or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government
official or employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Management</U>. During the past five year period, no current or former officer or director or, to the Knowledge of the Company, stockholder
of the Company or any of its Subsidiaries has been the subject of any matter that would require disclosure under Paragraph (f) of Rule
401 of Regulation S-K that has not been publicly disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Transactions With Affiliates</U>. Except as set forth on <U>Schedule 3(q)</U>, no current employee, director, officer or, to the Knowledge
of the Company, any former employee, director or officer, any stockholder of the Company or its Subsidiaries, affiliate of any thereof
who occupied such role during the past 12 months, or any relative with a relationship no more remote than first cousin of any of the
foregoing, is presently, or has ever been in the last 12 months, (i) a party to any transaction with the Company or its Subsidiaries
(including any contract, agreement or other arrangement providing for the furnishing of services by, or rental of real or personal property
from, or otherwise requiring payments to, any such director, officer or stockholder or such associate or affiliate or relative) or (ii)
the direct or indirect owner of an interest in any corporation, firm, association or business organization which is a competitor, supplier
or customer of the Company or its Subsidiaries (except for a passive investment (direct or indirect) in less than 5% of the common stock
of a company whose securities are publicly traded on or quoted), nor does any such Person receive income from any source other than the
Company or its Subsidiaries which relates to the business of the Company or its Subsidiaries or should properly accrue to the Company
or its Subsidiaries. Except as set forth on <U>Schedule 3(q)</U>, no employee, officer, stockholder or director of the Company or any
of its Subsidiaries or member of his or her immediate family is indebted to the Company or its Subsidiaries, as the case may be, nor
is the Company or any of its Subsidiaries indebted (or committed to make loans or extend or guarantee credit) to any of them, other than
(i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf of the Company, and (iii)
for other standard employee benefits made generally available to all employees or executives (including stock option agreements outstanding
under any stock option plan approved by the board of directors of the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Equity Capitalization</U>. As of the Execution Date, the authorized capital stock of the Company consists of (i) 50,000,000 shares
of Common Stock, of which as of the Execution Date, 10,000,000 are issued and outstanding and 40,000,000 are reserved for issuance pursuant
to options, warrants and equity compensation plans, and (ii) 5,000,000 shares of preferred stock, $0.01 par value per share and, as of
the Execution Date, of which 5,000 are outstanding designated as Series A Preferred Stock. Immediately prior to the Initial Closing Date,
the Company will be a wholly owned subsidiary of Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Absence of Litigation</U>. There is no action, suit, arbitration or other legal, administrative or other governmental investigation,
inquiry or proceeding (whether federal, state, local or foreign) pending or, to the best of the Company&rsquo;s Knowledge, threatened
against or affecting the Company or any of its Subsidiaries or any of their respective properties, assets, capital stock or businesses
or any of the Company&rsquo;s or any of its Subsidiaries&rsquo; officers or directors that if adversely determined would reasonably be
expected to have a Material Adverse Effect. <U>Schedule 3(t)</U> lists all of the Company&rsquo;s pending actions, suits, arbitrations
and other legal, administrative or other governmental investigations, inquiries and proceedings. After reasonable inquiry of its executive
officers, the Company is not aware of any fact which might result in or form the basis for any such action, suit, arbitration, investigation,
inquiry or other proceeding. Neither the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree,
determination or award of any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Acknowledgement Regarding Buyers&rsquo; Trading Activity</U>. It is understood and acknowledged by the Company (a) (i) that none of
the Buyers have been asked by the Company or its Subsidiaries to agree, nor has any Buyer agreed with the Company or its Subsidiaries,
to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities
issued by the Company or to hold the Securities for any specified term; and (ii) that each Buyer shall not be deemed to have any affiliation
with or control over any arm&rsquo;s length counter party in any &ldquo;derivative&rdquo; transaction. The Company further understands
and acknowledges that one or more Buyers may engage in hedging and/or trading activities at various times during the period that the
Securities are outstanding, including, without limitation, during the periods that the value of the Conversion Shares and/or the Warrant
Shares are being determined and (b) such hedging and/or trading activities, if any, can reduce the value of the existing stockholders&rsquo;
equity interest in the Company both at and after the time the hedging and/or trading activities are being conducted. The Company acknowledges
that such aforementioned hedging and/or trading activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Shell Company Status</U>. The Company is not an issuer identified in Rule 144(i)(1) of the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>No Disqualification Events</U>. With respect to Securities to be offered and sold hereunder in reliance on Rule 506 under the 1933
Act (&ldquo;<U>Regulation D Securities</U>&rdquo;), none of the Company, any of its predecessors, any affiliated issuer, any director,
executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;
and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;) is subject to any Disqualification Event, except for a Disqualification Event
covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject
to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and
has furnished to the Buyers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Other Covered Persons</U>. The Company is not aware of any Person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of Buyers or potential purchasers in connection with the sale of any Regulation
D Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B>COVENANTS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Best Efforts</U>. Each party shall use its best efforts to timely satisfy each of the covenants below and the conditions to be satisfied
by it as provided in <U>Sections 6</U> and <U>7</U> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Use of Proceeds</U>. The Company and Parent shall use the proceeds from the sale of the Securities for general corporate purposes,
including for expenses in connection with the consummating the Spin-Off.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Reporting Status</U>. Commencing on the Public Company Date (as defined below) until one year after no Preferred Shares or Warrants
are outstanding (the &ldquo;<U>Reporting Period</U>&rdquo;), the Company shall timely file all reports required to be filed with the
SEC pursuant to the 1934 Act, and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act
even if the 1934 Act or the rules and regulations thereunder would no longer require or otherwise permit such termination. As used herein,
&ldquo;<U>Public Company Date</U>&rdquo; means the date on which the shares of Common Stock of the Company (or its direct or indirect
successor, subsidiary or parent company, whose securities are issued or issuable to holders of Common Stock), whether as a result of
the Spin-Off, a public offering, merger, reverse merger, recapitalization, reorganization or otherwise, are registered under the 1934
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Listing</U>. As of the Public Company Date, the Company <U>and Parent</U> shall have secured the listing or quotation of the Conversion
Shares and Warrant Shares upon NASDAQ (such primary exchange, the &ldquo;<U>Principal Market</U>&rdquo;) (the date such listing initially
occurs, the &ldquo;<U>Listing Date</U>&rdquo;) and shall maintain, in accordance with this Agreement, the listing or quotation of all
additional Conversion Shares and Warrant Shares from time to time issued under the terms of the Transaction Documents. The Company shall
maintain the listing or quotation of the Conversion Shares and Warrant Shares on the Principal Market, and neither the Company nor any
of its Subsidiaries shall take any action which would be reasonably expected to result in the delisting or suspension of the Common Stock
on the Principal Market. Enveric shall pay all fees and expenses in connection with satisfying its obligations under this <U>Section
4(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fees</U>. Subject to <U>Section 8</U> below, at the Initial Closing and the Final Closing, the Company shall reimburse [Buyer]
or its designee(s) $25,000 and $75,000, respectively, for all costs and expenses incurred in connection with the transactions contemplated
by the Transaction Documents (including all legal fees and disbursements in connection therewith, documentation and implementation of
the transactions contemplated by the Transaction Documents and due diligence in connection therewith), which amount may be withheld by
such Buyer from its Purchase Price at each Closing to the extent not previously reimbursed by the Company. Notwithstanding the foregoing,
in no event will the costs and expenses of [Buyer] reimbursed by the Company pursuant to this <U>Section 4(e)</U> exceed $100,000
with respect to the Closings without the prior approval of the Company. The Company shall be responsible for the payment of any placement
agent&rsquo;s fees, financial advisory fees, or broker&rsquo;s commissions relating to or arising out of the transactions contemplated
hereby but only to the extent that the Company has agreed with any such party to pay such fees. The Company shall pay, and hold each
Buyer harmless against, any liability, loss or expense (including, without limitation, reasonable attorney&rsquo;s fees and out-of-pocket
expenses) arising in connection with any claim relating to any such payment. Except as otherwise set forth in the Transaction Documents,
each party to this Agreement shall bear its own expenses in connection with the sale of the Securities to the Buyers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Pledge of Securities</U>. The Company acknowledges and agrees that the Securities may be pledged by an Investor in connection with
a bona fide margin agreement or other loan or financing arrangement that is secured by the Securities. The pledge of Securities shall
not be deemed to be a transfer, sale or assignment of the Securities hereunder, and no Investor effecting a pledge of Securities shall
be required to provide the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or
any other Transaction Document, including, without limitation, <U>Section 2(g)</U> hereof; provided that an Investor and its pledgee
shall be required to comply with the provisions of <U>Section 2(g)</U> hereof in order to effect a sale, transfer or assignment of Securities
to such pledgee. The Company hereby agrees to execute and deliver such documentation as a pledgee of the Securities may reasonably request
in connection with a pledge of the Securities to such pledgee by an Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Disclosure of Transactions and Other Material Information</U>. On or before 9:30 a.m., New York time, on the fourth (4th) Business
Day after the date of this Agreement, Enveric shall file a Current Report on Form 8-K describing all the material terms of the transactions
contemplated by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including,
without limitation, this Agreement and the forms of all exhibits to this Agreement) (including all attachments and content required by
the applicable disclosure regulations, the &ldquo;<U>8-K Filing</U>&rdquo;). From and after the filing of the 8-K Filing, Enveric shall
have disclosed all material, non-public information (if any) provided to any of the Buyers by the Company, Enveric or any of its Subsidiaries
or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction
Documents. In addition, effective upon the filing of the 8-K Filing, each of the Company and Enveric acknowledges and agrees that any
and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, Enveric, any of its
Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers
or any of their affiliates, on the other hand, shall terminate. The Company shall not, and shall cause each of its Subsidiaries and its
and each of their respective officers, directors, employees and agents, not to, provide any Buyer with any material, nonpublic information
regarding the Company or any of its Subsidiaries from and after the Execution Date without the express prior written consent of such
Buyer. If a Buyer has, or believes it has, received any such material, nonpublic information regarding the Company or any of its Subsidiaries,
it may provide the Company with written notice thereof. The Company shall, within two (2) Trading Days of receipt of such notice, make
public disclosure of such material, nonpublic information. In the event of a breach of the foregoing covenant by the Company, any of
its Subsidiaries, or any of its or their respective officers, directors, employees and agents, in addition to any other remedy provided
herein or in the Transaction Documents, a Buyer shall have the right to make a public disclosure, in the form of a press release, public
advertisement or otherwise, of such material, nonpublic information without the prior approval by the Company, its Subsidiaries, or any
of its or their respective officers, directors, employees or agents. No Buyer shall have any liability to the Company, its Subsidiaries,
or any of its or their respective officers, directors, employees, stockholders or agents for any such disclosure. To the extent that
the Company delivers any material, non-public information to a Buyer without such Buyer&rsquo;s consent, the Company hereby covenants
and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty not to trade on the basis of, such material,
non-public information. Subject to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue any press releases
or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled,
without the prior approval of any Buyer, to make any press release or other public disclosure with respect to such transactions as is
required by applicable law and regulations, provided that each Buyer shall be consulted by the Company in connection with any such press
release or other public disclosure prior to its release. Without the prior written consent of any applicable Buyer, neither the Company
nor any of its Subsidiaries or affiliates shall disclose the name of such Buyer in any filing, announcement, release or otherwise, except
as the Company has been advised by its counsel as may be required by law including the Rules of the SEC or in response to written comments
of the Staff of the SEC. Notwithstanding the foregoing, in no event will the Company have an obligation to disclose any information which
a Buyer receives from a member of the Company&rsquo;s Board of Directors that is an affiliate of such Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Corporate Existence</U>. So long as any Buyer beneficially owns any Securities, the Company shall (i) maintain its corporate existence
and (ii) not be party to any Fundamental Transaction unless the Company is in compliance with the applicable provisions governing &ldquo;<U>Fundamental
Transactions</U>&rdquo; as such term is defined and set forth in the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Reservation of Shares</U>. The Company shall take all action necessary to at all times have authorized, and reserved for the purpose
of issuance, no less than 100% of the maximum number of shares of Common Stock issuable (i) upon conversion of the maximum number of
Preferred Shares issued (assuming for purposes hereof, that the Preferred Shares are convertible at the Conversion Price and without
taking into account any limitations on the conversion of the Preferred Shares set forth in the Certificate of Designations) and (ii)
upon exercise of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth in the Warrants),
in each case, determined as if issued as of the Trading Day immediately preceding the applicable date of determination (the &ldquo;<U>Required
Reserved Amount</U>&rdquo;). If at any time the number of shares of Common Stock authorized and reserved for issuance is not sufficient
to meet the Required Reserved Amount, the Company will promptly take all corporate action necessary to authorize and reserve a sufficient
number of shares, including, without limitation, calling a special meeting of stockholders to authorize additional shares to meet the
Company&rsquo;s obligations under <U>Section 3(c)</U>, in the case of an insufficient number of authorized shares, obtain stockholder
approval of an increase in such authorized number of shares, and voting any treasury shares of the Company in favor of an increase in
the authorized shares of the Company to ensure that the number of authorized shares is sufficient to meet the Required Reserved Amount.
In connection with any such vote, each Buyer hereby agrees that it shall, if requested by the Company, vote all shares of capital stock
held by such Buyer in favor of any such increase in the authorized number of shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Conduct of Business</U>. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance
or regulation of any governmental entity, except where such violations would not result, either individually or in the aggregate, in
a Material Adverse Effect. The Company and its Subsidiaries shall at all times be in compliance with the Foreign Corrupt Practices Act;
the PATRIOT Act, and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations; and the laws, regulations and
Executive Orders and sanctions programs administered by the OFAC, including, without limitation, the &ldquo;Anti-Money Laundering/OFAC
Laws&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Public Information</U>. At any time during the period commencing on the Public Company Date and ending one year from the Public Company
Date, if (A) a registration statement is not available for the resale of all of the Securities, may be sold without restriction or limitation
pursuant to Rule 144 and without the requirement to be in compliance with Rule 144(c)(1) , if the Company shall (i) fail for any reason
to satisfy the requirements of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirement
under Rule 144(c) or (ii) if the Company becomes an issuer described in Rule 144(i)(1)(i) , and the Company shall fail to satisfy any
condition set forth in Rule 144(i)(2), and (B) any such failure continues for more than fifteen (15) Trading Days (a &ldquo;<U>Public
Information Failure</U>&rdquo;) then, as partial relief for the damages to any holder of Securities by reason of any such delay in or
reduction of its ability to sell the Securities (which remedy shall not be exclusive of any other remedies available at law or in equity),
the Company shall pay to each such holder an amount in cash equal to one percent (1.0%) of the aggregate Purchase Price of such holder&rsquo;s
Securities (less any Common Stock previously sold) on the day of a Public Information Failure and on every thirtieth day (pro-rated for
periods totaling less than thirty days) thereafter until the earlier of (i) the date such Public Information Failure is cured and (ii)
such time that such public information is no longer required pursuant to Rule 144. Notwithstanding anything contained herein to the contrary,
aggregate Public Information Failure Payments shall not exceed 10% of the aggregate Purchase Price. The payments to which a holder shall
be entitled pursuant to this <U>Section 4(k)</U> are referred to herein as &ldquo;<U>Public Information Failure Payments.</U>&rdquo;
Public Information Failure Payments shall be paid on the earlier of (I) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (II) the third Business Day after the event or failure giving rise to the Public Information Failure
Payments is cured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Participation in Future Financing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
From the date hereof until the 18-month anniversary of the Final Closing Date, upon any issuance by the Company or any of its Subsidiaries
of Common Stock or Common Stock Equivalents for cash consideration, indebtedness or a combination of units thereof (a &ldquo;<U>Subsequent
Financing</U>&rdquo;), the Buyers shall have the right to participate in up to an aggregate amount of the Subsequent Financing equal
to 50% of the Subsequent Financing (the &ldquo;Participation Maximum&rdquo;), pro rata to each Buyer&rsquo;s Preferred Shares Subscription
Amount, on the same terms, conditions and price provided for in the Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Between the time period of 4:00 pm (New York City time) and 6:00 pm (New York City time) on the Trading Day immediately prior to the
Trading Day of the expected announcement of the Subsequent Financing (or, if the Trading Day of the expected announcement of the Subsequent
Financing is the first Trading Day following a holiday or a weekend (including a holiday weekend), between the time period of 4:00 pm
(New York City time) on the Trading Day immediately prior to such holiday or weekend and 2:00 pm (New York City time) on the day immediately
prior to the Trading Day of the expected announcement of the Subsequent Financing), the Company shall deliver to each Buyer a written
notice of the Company&rsquo;s intention to effect a Subsequent Financing (a &ldquo;Subsequent Financing Notice&rdquo;), which notice
shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder
and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet and
transaction documents relating thereto as an attachment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Any Buyer desiring to participate in such Subsequent Financing must provide written notice to the Company by 6:30 am (New York City time)
on the third Trading Day following the date on which the Subsequent Financing Notice is delivered to the Buyer (the &ldquo;<U>Notice
Termination Time</U>&rdquo;) that the Buyer is willing to participate in the Subsequent Financing, the amount of the Buyer&rsquo;s participation,
and representing and warranting that the Buyer has such funds ready, willing, and available for investment on the terms set forth in
the Subsequent Financing Notice. If the Company receives no such notice from a Buyer as of such Notice Termination Time, the Buyer shall
be deemed to have notified the Company that it does not elect to participate in such Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
If, by the Notice Termination Time, notifications by the Buyers of their willingness to participate in the Subsequent Financing (or to
cause their designees to participate) is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company
may effect the remaining portion of such Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing
Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
If, by the Notice Termination Time, the Company receives responses to a Subsequent Financing Notice from Buyers seeking to purchase more
than the aggregate amount of the Participation Maximum, the Buyer shall have the right to purchase its Pro Rata Portion (as defined below)
of the Participation Maximum. &ldquo;<U>Pro Rata Portion</U>&rdquo; means the ratio of (x) the Preferred Shares Subscription Amount purchased
by a Buyer participating under this <U>Section 4(l)</U> and (y) the sum of the aggregate Preferred Shares Subscription Amounts purchased
by all Buyers participating under this <U>Section 4(l)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
The Company must provide the Buyers with a second Subsequent Financing Notice, and the Buyers will again have the right of participation
set forth above in this <U>Section 4(l)</U>, if the definitive agreement related to the initial Subsequent Financing Notice is not entered
into for any reason on the terms set forth in such Subsequent Financing Notice within two (2) Trading Days after the date of delivery
of the initial Subsequent Financing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
The Company and each Buyer agree that, if any Buyer elects to participate in the Subsequent Financing, the transaction documents related
to the Subsequent Financing shall not include any term or provision that, directly or indirectly, will, or is intended to, exclude one
or more of the Buyers from participating in a Subsequent Financing, including, but not limited to, provisions whereby the Buyer shall
be required to agree to any restrictions on trading as to any the securities of the Company or be required to consent to any amendment
to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written
consent of the Buyer. In addition, the Company and each Buyer agree that, in connection with a Subsequent Financing, the transaction
documents related to the Subsequent Financing shall include a requirement for the Company to issue a widely disseminated press release
by 9:30 am (New York City time) on the Trading Day of execution of the transaction documents in such Subsequent Financing (or, if the
date of execution is not a Trading Day, on the immediately following Trading Day) that discloses the material terms of the transactions
contemplated by the transaction documents in such Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
Notwithstanding anything to the contrary in this <U>Section 4(l)</U> and unless otherwise agreed to by the Buyer, the Company shall either
confirm in writing to the Buyer that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose
its intention to issue the securities in the Subsequent Financing, in either case in such a manner such that the Buyer will not be in
possession of any material, non-public information, by 9:30 am (New York City time) on the second (2nd) Trading Day following date of
delivery of the Subsequent Financing Notice. If by 9:30 am (New York City time) on such second (2nd) Trading Day, no public disclosure
regarding a transaction with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction
has been received by the Buyer, such transaction shall be deemed to have been abandoned and the Buyer shall not be deemed to be in possession
of any material, non-public information with respect to the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
Notwithstanding the foregoing, this <U>Section 4(l)</U> shall not apply in connection with the issuance of any Excluded Securities. &ldquo;<U>Excluded
Securities</U>&rdquo; means (i) shares of Common Stock, restricted stock units or standard options to purchase Common Stock issued to
directors, officers, employees or consultants of the Company for services rendered to the Company in their capacity as such pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company; (ii) shares
of Common Stock issued upon the conversion or exercise of Convertible Securities issued prior to the Execution Date, provided that the
conversion price of any such Convertible Securities is not lowered (other than in accordance with the terms thereof in effect as of the
Execution Date or in connection with stock splits or combinations) from the conversion price in effect as of the Execution Date and none
of such Convertible Securities are amended to increase the number of shares issuable thereunder (other than in accordance with the terms
thereof in effect as of the Execution Date or in connection with stock splits or combinations); (iii) the shares of Common Stock issuable
upon conversion of the Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations; (iv) the shares of Common
Stock issuable upon exercise of the Warrants or warrants required to be issued under this Agreement pursuant to which the Preferred Shares
were issued; (v) securities issued to any placement agent or other registered broker-dealers as reasonable commissions or fees in connection
with any financing transactions or securities issued to service providers including investor and public relations firms; (vi) securities
issued pursuant to a merger, acquisition or similar transaction; or (vii) a strategic transaction approved by a majority of the disinterested
directors of the Company, provided that any such issuance shall only be to a person which is, itself or through its subsidiaries, an
operating company in a business synergistic with the business of the Company and in which the Company receives benefits in addition to
the investment of funds but shall not include a transaction in which the Company is issuing securities to an entity whose primary business
is investing in securities. <U>Provided</U>, <U>however</U>, that securities issued to a registered broker-dealer as compensation for
the services rendered in connection for services for transactions described in clauses (vi) and (vii) shall be Excluded Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Taxes</U>. The Company will pay, and save and hold the Buyers harmless from any and all liabilities (including interest and penalties)
with respect to, or resulting from any delay or failure in paying, stamp and other taxes (other than income taxes), if any, which may
be payable or determined to be payable on the execution and delivery or acquisition of the Preferred Shares, Warrants, Conversion Shares
or Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>D&amp;O Insurance</U>. If not already obtained, the Company shall obtain such director&rsquo;s and officer&rsquo;s insurance in such
form, with such carrier and in such amounts as is typical for companies similarly situated to the Company (the &ldquo;<U>D&amp;O Insurance</U>&rdquo;)
within 90 days following the Initial Closing, and, for so long as any Preferred Shares remain outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Books and Records</U>. The Company will keep proper books of record and account, in which full and correct entries shall be made of
all financial transactions and the assets and business of the Company and its Subsidiaries in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Notice of Disqualification Events</U>. The Company will notify the Buyers in writing, prior to the applicable Closing Date of (i)
any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification
Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Cooperation</U>. The Company and Parent agrees to use its reasonable best efforts in connection with the closing of the Spin-Off and
agrees to take all action necessary to consummate the closing of the Spin-Off in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>DTC Eligibility</U>. As of the Public Company Date, for so long as any Convertible Shares or Warrant Sahres are outstanding, the Company
will employ as the transfer agent for the Common Stock a participant in the Depository Trust Company Automated Securities Transfer Program
and cause the Common Stock to be transferable pursuant to such program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(s)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Offering Restrictions</U>. Until the date that is
ten (10) months after the Final Closing, the Company shall not issue any common stock or common stock equvilants at a price per share
lower than the Unit Price. Notwithstanding the foregoing, after the Final Closing Date, upon the earlier of (a) (i) the closing bid price
for ten consecutive Trading Days (the &ldquo;<U>Measurement Period</U>&rdquo;) exceeds 125% of the Unit Price (subject to adjustments
for splits, dividends and the like), (ii) the daily dollar trading volume of the Common Stock for each Trading Day during such Measurement
Period is at least $200,000, and (iii) all of the Equity Conditions (as defined below) have been met on each Trading Day during such
Measurement Period, and (b) the Company&rsquo;s consummation of an equity financing for the sale of equity securities equal to at least
$5 million in the aggregate at a price per share that exceeds the Unit Price, this Section 4(s) shall no longer be in effect. &ldquo;<U>Equity
Conditions</U>&rdquo; means (a) (i) there is an effective registration statement pursuant to which the Buyers are permitted to utilize
the prospectus thereunder to resell all of the Conversion Shares and Warrant Shares issuable pursuant to the Transaction Documents, or
(ii) all of the Conversion Shares and Warrant Shares issuable pursuant to the Transaction Documents (and shares issuable in lieu of cash
payments of dividends) may be resold pursuant to Rule 144 without volume or manner-of-sale restrictions or current public information
requirements as determined by the counsel to the Company as set forth in a written opinion letter to such effect, addressed and acceptable
to the Transfer Agent and the affected Buyers, (b) the Common Stock is trading on the Principal Market and all of the shares of Common
Stock issuable pursuant to the Transaction Documents are listed or quoted for trading on such Principal Market, (c) there is a sufficient
number of authorized, but unissued and otherwise unreserved, shares of Common Stock for the issuance of all of the shares then issuable
pursuant to the Transaction Documents, (d) the applicable Buyer is not in possession of any information provided by the Company, any
of its Subsidiaries, or any of their officers, directors, employees, agents or affiliates, that constitutes, or may constitute, material
non-public information, and (e) the Company is not in material default of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Board Appointment</U>. The Company agrees that following the Final Closing Date, the board of directors of the Company shall take
all necessary actions to appoint a director selected by the Placement Agent to the Company&rsquo;s board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B>REGISTER.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to each holder of Securities), a register for the Preferred Shares in which the Company shall record the name and address of the Person
in whose name the Preferred Shares have been issued (including the name and address of each transferee), the number of Preferred Shares
held by such Person and the number of Conversion Shares issuable upon conversion of the Preferred Shares held by such Person. The Company
shall keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B>CONDITIONS TO THE COMPANY&rsquo;S OBLIGATION TO SELL.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of the Company hereunder to issue and sell the Preferred Shares and the related Warrants, as applicable, to each Buyer at
the Closings is subject to the satisfaction, at or before each Closing Date, of each of the following conditions, provided that these
conditions are for the Company&rsquo;s sole benefit and may be waived by the Company at any time in its sole discretion by providing
each Buyer with prior written notice thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Such Buyer shall have executed each of the Transaction Documents to which it is a party and delivered the same to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Such Buyer shall have delivered to the Company Purchase Price (less, in the case of any Buyer, the amount withheld by such Buyer pursuant
to <U>Section 4(e)</U>) for the Preferred Shares being purchased by such Buyer at such Closing by wire transfer of immediately available
funds pursuant to the wire instructions provided by the Escrow Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The representations and warranties of such Buyer shall be true and correct as of the date when made and as of such Closing Date as though
made at that time (except for representations and warranties that speak as of a specific date, which shall be true and correct as of
such specified date), and such Buyer shall have performed, satisfied and complied with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by such Buyer at or prior to such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B>CONDITIONS TO EACH BUYER&rsquo;S OBLIGATION TO PURCHASE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of each Buyer hereunder to purchase the Preferred Shares and the related Warrants, as applicable, at the Closings is subject
to the satisfaction, at or before each Closing Date, of each of the following conditions, provided that these conditions are for each
Buyer&rsquo;s sole benefit and may be waived by such Buyer at any time in its sole discretion by providing the Company with prior written
notice thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company shall have duly executed and delivered to such Buyer each of the Transaction Documents and the stock certificates or book-entry
holding statements representing the Preferred Shares being purchased by such Buyer at such Closing pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company and each of its
Subsidiaries in each such entity&rsquo;s jurisdiction of formation issued by the Secretary of State (or equivalent) of such jurisdiction
of formation as of a date within ten (10) days of such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Company shall have delivered to such Buyer a certificate evidencing the Company&rsquo;s good standing issued by the Secretary of
State (or comparable office) of the State of Delaware as of a date within ten (10) days of such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
The Company shall have delivered to such Buyer a certified copy of the Certificate of Incorporation as certified by the Secretary of
State of the State of Delaware within ten (10) days of such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
The Company shall have duly executed the Registration Rights Agreement (the &ldquo;<U>RRA</U>&rdquo;) in the form attached hereto as
<U>Exhibit C</U>, and with respect to the Final Closing, all of the Underlying Shares are included in an effective registration statement
for resale under the prospectus included therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
The Company shall have delivered to such Buyer a certificate, executed by the Secretary of the Company and dated as of such Closing Date,
as to (i) the resolutions consistent with <U>Section 3(b)</U> as adopted by the Company&rsquo;s board of directors in a form reasonably
acceptable to such Buyer, (ii) the Certificate of Incorporation and (iii) the Bylaws, each as in effect at such Closing, in the form
attached hereto as <U>Exhibit D</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
The representations and warranties of the Company shall be true and correct as of the date when made and as of such Closing Date as though
made at that time (except for representations and warranties that speak as of a specific date, which shall be true and correct as of
such specified date). The Company shall have performed, satisfied and complied in all respects with the covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by the Company at or prior to such Closing Date, in
each case, in all material respects. Such Buyer shall have received a certificate, executed by the Chief Executive Officer of the Company,
dated as of such Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by such Buyer in the
form attached hereto as <U>Exhibit E</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
The Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of
the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
The Certificate of Designations in the form attached hereto as <U>Exhibit A</U> shall have been filed with the Secretary of State of
the State of Delaware and shall be in full force and effect, enforceable against the Company in accordance with its terms and shall not
have been amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
The Company shall have delivered to such Buyer such other documents relating to the transactions contemplated by this Agreement as such
Buyer or its counsel may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
The Company shall deliver a legal opinion to the Buyers, reasonably acceptable to the Buyers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<B>TERMINATION.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Initial Closing shall not have occurred with respect to a Buyer on or before fifteen (15) Business Days from the Execution
Date due to the Company&rsquo;s or such Buyer&rsquo;s failure to satisfy the conditions set forth in <U>Sections 6</U> and <U>7</U> above
(and the nonbreaching party&rsquo;s failure to waive such unsatisfied condition(s)), the nonbreaching party shall have the option to
terminate this Agreement with respect to such breaching party at the close of business on such date by delivering a written notice to
that effect to each other party to this Agreement and without liability of any party to any other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B>MISCELLANEOUS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Parent Guarantee</U>. The Parent hereby unconditionally and irrevocably guarantees the payment in full of the Put Purchase Price (as
defined in the Certificate of Designation), in cash, if the Buyer requires the SpinCo to repurchase the shares of Preferred Stock pursuant
to Section 6 of the Certificate of Designation (the &ldquo;<U>Guaranteed Obligation</U>&rdquo;). For the avoidance of doubt, the Parent
shall remain liable for the payment of the entire amount of the Put Purchase Price (less amounts actually paid or distributed in cash
to the Purchaser under the Certificate of Designations) notwithstanding that SpinCo may have insufficient net assets to distribute the
entire Liquidation Preference and accrued and unpaid dividends to Purchaser upon a Liquidation Event and notwithstanding any provision
of Section 11 or Section 12 of the Certificate of Designation. The Parent agrees that the foregoing obligation of Parent is a guarantee
of payment and not collection and the Parent is liable for the Guaranteed Obligations as a primary obligation of the Parent. The Parent
waives all rights and defenses of a surety and any other defenses to enforcement of this <U>Section 9(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Governing Law; Jurisdiction; Jury Trial</U>. All questions concerning the construction, validity, enforcement and interpretation of
this Agreement shall be governed by the internal laws of the State of Delaware, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of
any jurisdictions other than the State of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the state
and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action
or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing
a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any manner permitted by law. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST,
A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Counterparts</U>. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided
that an e-mail signature shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect
as if the signature were an original, not an e-mail signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Headings</U>. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Severability</U>. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express,
without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity
or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations
of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor
in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of
which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Entire Agreement; Amendments</U>. This Agreement and the other Transaction Documents supersede all other prior oral or written agreements
between the Buyers, the Company, their affiliates and Persons acting on their behalf with respect to the matters discussed herein, and
this Agreement, the other Transaction Documents and the instruments referenced herein and therein contain the entire understanding of
the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the
Company nor any Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. Provisions of this Agreement
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively),
only with the written consent of the Company and either (i) the holders of at least a majority of the Preferred Shares outstanding as
of the applicable date of determination, which must include [ Buyer] as long as [Buyer] (or any of its affiliates) owns
at least five percent (5%) of the Preferred Shares issued pursuant to this Agreement, or (ii) [Buyer] as long as [Buyer]
(or any of its affiliates) owns at least five percent (5%) of the Preferred Shares issued pursuant to this Agreement (the &ldquo;<U>Required
Holders</U>&rdquo;); provided that any such amendment or waiver that complies with the foregoing but that disproportionately, materially
and adversely affects the rights and obligations of any Buyer relative to the comparable rights and obligations of the other Buyers shall
require the prior written consent of such adversely affected Buyer. Any amendment or waiver effected in accordance with this <U>Section
9(e)</U> shall be binding upon each Buyer and holder of Securities and the Company. No such amendment shall be effective to the extent
that it applies to less than all of the Buyers or holders of Securities. No consideration shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration (other than
the reimbursement of legal fees) also is offered to all of the parties to the Transaction Documents, holders of Preferred Shares or holders
of Warrants, as the case may be. The Company has not, directly or indirectly, made any agreements with any Buyers relating to the terms
or conditions of the transactions contemplated by the Transaction Documents except as set forth in the Transaction Documents. Without
limiting the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise
or has any other obligation to provide any financing to the Company or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Notices</U>. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement
must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent
by e-mail (provided confirmation of transmission is electronically generated and kept on file by the sending party); or (iii) one (1)
Business Day after deposit with an overnight courier service, in each case properly addressed to the party to receive the same. The addresses
and email addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acanna
Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4851
Tamiami Trail N, Suite 200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naples,
FL 34103</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy (for informational purposes only) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynes
and Boone, LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30
Rockefeller Plaza, 26th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10112,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(212) 659-7300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>rick.werner@haynesboone.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144.7pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Rick A. Werner, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to a Buyer, to its address and email address set forth on the <U>Schedule of Buyers</U>, with copies to such Buyer&rsquo;s representatives
as set forth on the <U>Schedule of Buyers</U>,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy (for informational purposes only) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in">_____________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">_____________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U></U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other address and/or email address and/or to the attention of such other Person as the recipient party has specified by written
notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by
the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender&rsquo;s
email containing the time, date, recipient e-mail and an image of the first page of such transmission or (C) provided by an overnight
courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from an overnight courier service in accordance
with clause (i), (ii) or (iii) above, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors
and assigns, including any purchasers of the Preferred Shares or the Warrants. The Company shall not assign this Agreement or any rights
or obligations hereunder without the prior written consent of the Required Holders, including by way of a Fundamental Transaction (unless
the Company is in compliance with the applicable provisions governing Fundamental Transactions set forth in the Certificate of Designations
and the Warrants). A Buyer may assign some or all of its rights hereunder without the consent of the Company, in which event such assignee
shall be deemed to be a Buyer hereunder with respect to such assigned rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>No Third Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that each
Indemnitee shall have the right to enforce the obligations of the Company with respect to <U>Section 9(k)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Survival</U>. Unless this Agreement is terminated under <U>Section 8</U>, the representations, warranties, agreements and covenants
hereunder shall survive the Final Closing and the delivery, conversion and/or exercise of the Securities, as applicable. Each Buyer shall
be responsible only for its own representations, warranties, agreements and covenants hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Further Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In consideration of each Buyer&rsquo;s execution and delivery of the Transaction Documents and acquiring the Securities thereunder and
in addition to all of the Company&rsquo;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify
and hold harmless each Buyer and each other holder of the Securities and all of their stockholders, partners, members, officers, directors,
employees and direct or indirect investors and any of the foregoing Persons&rsquo; agents or other representatives (including, without
limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the &ldquo;<U>Indemnitees</U>&rdquo;)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is
sought), and including reasonable attorneys&rsquo; fees and disbursements (the &ldquo;<U>Indemnified Liabilities</U>&rdquo;), incurred
by any Indemnitee as a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty
made by the Company in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (b)
any breach of any covenant, agreement or obligation of the Company contained in the Transaction Documents or any other certificate, instrument
or document contemplated hereby or thereby or (c) any cause of action, suit or claim brought or made against such Indemnitee by a third
party (including for these purposes a derivative action brought on behalf of the Company) and arising out of or resulting from (i) the
execution, delivery, performance or enforcement of the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby, (ii) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of
the issuance of the Securities, (iii) any disclosure made by such Buyer pursuant to <U>Section 4(h)</U>, or (iv) the status of such Buyer
or holder of the Securities as an investor in the Company pursuant to the transactions contemplated by the Transaction Documents. To
the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Promptly after receipt by an Indemnitee under this <U>Section 9(k)</U> of notice of the commencement of any action or proceeding (including
any governmental action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim for indemnification in respect
thereof is to be made against any indemnifying party under this <U>Section 9(k)</U>, deliver to the indemnifying party a written notice
of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party
so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually
satisfactory to the indemnifying party and the Indemnitee; provided, however, that an Indemnitee shall have the right to retain its own
counsel with the fees and expenses of not more than one counsel for such Indemnitee to be paid by the indemnifying party, if, in the
reasonable opinion of counsel selected to defend the Indemnitee, the representation by such counsel of the Indemnitee and the indemnifying
party would be inappropriate due to actual or potential differing interests between such Indemnitee and any other party represented by
such counsel in such proceeding. Legal counsel referred to in the immediately preceding sentence shall be selected by the Investors holding
at least a majority of the Purchased Shares. The Indemnitee shall cooperate fully with the indemnifying party in connection with any
negotiation or defense of any such action or Indemnified Liabilities by the indemnifying party and shall furnish to the indemnifying
party all information reasonably available to the Indemnitee that relates to such action or Indemnified Liabilities. The indemnifying
party shall keep the Indemnitee fully apprised at all times as to the status of the defense or any settlement negotiations with respect
thereto. No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its prior written
consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying
party shall, without the prior written consent of the Indemnitee, which consent shall not be unreasonably withheld conditioned or delayed,
consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such Indemnitee of a release from all liability in respect to such Indemnified Liabilities
or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnitee
with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. No Indemnitee
shall enter into any settlement of any action or proceeding subject to this <U>Section 9(k)</U> without the prior written consent of
the indemnifying party. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement
of any such action shall not relieve such indemnifying party of any liability to the Indemnitee under this <U>Section 9(k)</U>, except
to the extent that the indemnifying party is prejudiced in its ability to defend such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The indemnification required by this <U>Section 9(k)</U> shall be made by periodic payments of the amount thereof during the course of
the investigation or defense, as and when bills are received or Indemnified Liabilities are incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
The indemnity agreements contained herein shall be in addition to (x) any cause of action or similar right of the Indemnitee against
the indemnifying party or others, and (y) any liabilities the indemnifying party may be subject to pursuant to the law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>No Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Remedies</U>. Each Buyer and each holder of the Securities shall have all rights and remedies set forth in the Transaction Documents
and all rights and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights
which such holders have under any law. Any Person having any rights under any provision of this Agreement shall be entitled to enforce
such rights specifically to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights
granted by law. Furthermore, the Company recognizes that in the event that it fails to perform, observe, or discharge any or all of its
obligations under the Transaction Documents, any remedy at law may prove to be inadequate relief to the Buyers. The Company therefore
agrees that the Buyers shall be entitled to seek temporary and permanent injunctive relief in any such case without the necessity of
proving actual damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) the Transaction Documents, whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the
Company does not timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to the Buyers hereunder or pursuant to any of the
other Transaction Documents or the Buyers enforce or exercise their rights hereunder or thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver
or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall
be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Reproduction of Documents</U>. This Agreement and all documents relating thereto, including, without limitation, (a) consents, waivers
and modifications which may hereafter be executed, (b) documents received by the Buyers on the Closing Dates (except for certificates
evidencing the Preferred Shares themselves), and (c) financial statements, certificates and other information previously or hereafter
furnished to the Buyers, may be reproduced by any Buyer by any photographic, photostatic, microfilm, micro-card, miniature photographic
or other similar process and any Buyer may destroy any original document so reproduced. All parties hereto agree and stipulate that any
such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not
the original is in existence and whether or not such reproduction was made by a Buyer in the regular course of business) and that any
enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Independent Nature of Buyers&rsquo; Obligations and Rights</U>. The obligations of each Buyer under any Transaction Document are several
and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance of the obligations
of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken
by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges that the Buyers do
not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Buyers
are in any way acting in concert or as a group, and the Company shall not assert any such claim with respect to such obligations or the
transactions contemplated by the Transaction Documents and the Company acknowledges that the Buyers are not acting in concert or as a
group with respect to such obligations or the transactions contemplated by the Transaction Documents. The Company acknowledges and each
Buyer confirms that it has independently participated in the negotiation of the transaction contemplated hereby with the advice of its
own counsel and advisors. Each Buyer shall be entitled to independently protect and enforce its rights, including, without limitation,
the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary for any other Buyer
to be joined as an additional party in any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Knowledge Definition</U>. &ldquo;<U>Knowledge of Company</U>&rdquo; or &ldquo;<U>Company&rsquo;s Knowledge</U>&rdquo; or any other
similar knowledge qualification, means to the knowledge, after due inquiry into the subject matter of such representation, warranty or
other statement and reasonable investigation, of any of the current officers or directors of the Company, and any other Company employee
who has responsibility with respect to the relevant subject matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>**
Signature Page Follows **</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> each Buyer, Enveric and the Company have caused their respective signature page to this Securities Purchase Agreement
to be duly executed as of the Execution Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY</U>:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Acanna
    Therapeutics, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 221.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
page &ndash; Securities Purchase Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> each Buyer, Enveric and the Company have caused their respective signature page to this Securities Purchase Agreement
to be duly executed as of the Execution Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Solely
    with respect to Sections 1(b), 4(b), 4(d), 4(g), 4(q) and 9,</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ENVERIC:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enveric
    Biosciences, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> each Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to
be duly executed as of the Execution Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BUYERS</U>:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>[______]</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
page &ndash; Securities Purchase Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
OF BUYERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">(1)</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 7%; font-weight: bold; text-align: center">(2)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(3)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(4)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(5)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(6)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(7)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(8)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(9)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 6%; font-weight: bold; text-align: center">(10)</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center"></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Buyer</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address and E-mail</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate Number of Preferred Shares to be Issued at the Initial Closing</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase Price of Preferred Shares to be Issued at the Initial Closing</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate Number of Preferred Shares to be Issued at the Final Closing</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate Number of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant Shares Underlying the Warrants to be Issued at the Final Closing</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase Price of Securities Issued at the Final Closing</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate Number of Preferred Shares</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate Purchase Price of Securities</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal Representative&rsquo;s Address and E-mail</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATIONS, PREFERENCES AND RIGHTS OF THE<BR>
SERIES A CONVERTIBLE PREFERRED STOCK OF<BR>
<FONT STYLE="text-transform: uppercase">Acanna Therapeutics, Inc.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Joseph Tucker, Chief Executive Officer of Acanna Therapeutics, Inc. (the &ldquo;<U>Corporation</U>&rdquo;), a corporation
organized and existing under the Delaware General Corporation Law (&ldquo;<U>DGCL</U>&rdquo;), in accordance with the provisions of Section
151 of the DGCL, does hereby certify:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
pursuant to the authority expressly conferred upon the Board of Directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;)
by the Corporation&rsquo;s Certificate of Incorporation, as amended (the &ldquo;<U>Certificate of Incorporation</U>&rdquo;), the Board
of Directors, by unanimous written consent of its directors pursuant to Section 141(f) of the DGCL, on May 4, 2022, adopted the following
resolutions in connection with designating shares of stock as Series A Convertible Preferred Stock, none of which shares have been issued:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
that the Board of Directors designates the Series A Convertible Preferred Stock and the number of shares constituting such series, and
fixes the rights, powers, preferences, privileges and restrictions relating to such series in addition to any set forth in the Certificate
of Incorporation as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF SERIES A CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Designation
and Number of Shares</U>. There shall hereby be created and established a series of preferred stock of the Corporation designated as
&ldquo;Series A Convertible Preferred Stock&rdquo; (the &ldquo;<U>Preferred Shares</U>&rdquo;). The authorized number of Preferred Shares
shall be 5,000 shares. Each Preferred Share shall have a par value of $0.01. Capitalized terms not defined herein shall have the meaning
as set forth in <U>Section 25</U> below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Ranking</U>.
Except to the extent that the Required Holders (as defined in the Purchase Agreement) expressly consent to the creation of Parity Stock
(as defined below) or Senior Preferred Stock (as defined below) in accordance with <U>Section 13</U> below, all shares of capital stock
of the Corporation shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions and
payments upon the liquidation, dissolution and winding up of the Corporation (such junior stock is referred to herein collectively as
&ldquo;<U>Junior Stock</U>&rdquo;). The rights of all such shares of capital stock of the Corporation shall be subject to the rights,
powers, preferences and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations,
without the prior express consent of the Required Holders, voting separate as a single class, the Corporation shall not hereafter authorize
or issue any additional or other shares of capital stock that is (i) of senior rank to the Preferred Shares in respect of the preferences
as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Corporation (collectively, the &ldquo;<U>Senior
Preferred Stock</U>&rdquo;), (ii) of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Corporation (collectively, the &ldquo;<U>Parity Stock</U>&rdquo;)
or (iii) any Junior Stock having a maturity date (or any other date requiring redemption or repayment of such shares of Junior Stock)
that is prior to the date that no Preferred Shares remain outstanding. Except as provided for herein, in the event of the merger or consolidation
of the Corporation into another corporation, the Preferred Shares shall maintain their relative rights, powers, designations, privileges
and preferences provided for herein for a period of at least two years following such merger or consolidation and no such merger or consolidation
shall cause results inconsistent therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Dividends
and Distributions</U>. From and after the Initial Closing Date, cumulative dividends on each Preferred Share shall, whether or not declared
by the Board of Directors and whether or not the Corporation has the funds available to pay and dividends that accrue, accrue at the
rate of 5% per annum on the Stated Value; provided, however, following the Final Closing Date all dividends on the Preferred Shares shall
automatically cease accruing. The Corporation shall pay such dividends in cash upon the earliest of (i) the date of any such Automatic
Conversion (with respect only to Preferred Shares being converted) with respect to all accrued but unpaid dividends, and (ii) a Liquidation
Event pursuant to Section 11 (such date, the &ldquo;<U>Dividend Payment Date</U>&rdquo;) (if any Dividend Payment Date is not a Trading
Day, the applicable payment shall be due on the next succeeding Trading Day). As long any Preferred Shares remain outstanding, no dividend
shall be declared or accrue on the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Automatic
Conversion</U>. Subject to the provisions of <U>Section &lrm;4(d)</U>, on or immediately prior to the Spin-Off Date (as defined in the
Securities Purchase Agreement), each Preferred Share shall be automatically converted into a number of validly issued, fully paid and
non-assessable shares of Common Stock (an &ldquo;<U>Automatic Conversion</U>&rdquo;) equal to the quotient of (x) the Stated Value and
(y) the Conversion Price (as defined below); provided, however, that to the extent that an Automatic Conversion would result in a Holder
and its other Attribution Parties (as defined below) exceeding the Beneficial Ownership Limitation set forth in <U>Section 4(d)</U>,
if applicable, then such Holder&rsquo;s Preferred Shares shall not be automatically converted into Common Stock and shall remain outstanding,
and such Holder shall benefit from all preferences and rights set forth in this Certificate of Designations to such extent (and shall
not be entitled to beneficial ownership of such shares of Common Stock as a result of such Automatic Conversion (and beneficial ownership)
to such extent), and the shares of Common Stock issuable upon the automatic conversion of Preferred Shares to such extent shall be held
in abeyance for such Holder until such time or times as conversion of such Preferred Shares would not result in such Holder and its other
Attribution Parties exceeding the Beneficial Ownership Limitation set forth in <U>Section 4(d)</U>, at which time or times such Holder
shall be issued such shares of Common Stock (and any shares of Common Stock granted or issued with respect to the shares of Common Stock
issuable upon conversion of Preferred Shares to be held similarly in abeyance) to the same extent as if there had been no such limitation.
Upon an Automatic Conversion, subject to the limitations set forth in the preceding sentence, the outstanding Preferred Shares shall
be converted automatically without any further action by the Holders of such shares and whether or not the certificates representing
such shares are surrendered to the Corporation or its transfer agent; provided, however, that the Corporation shall not be obligated
to issue certificates evidencing any Conversion Shares issuable upon such conversion unless the certificates evidencing such Preferred
Shares are either delivered to the Corporation or its transfer agent, or the holder notifies the Corporation or its transfer agent that
such certificates have been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation
from any loss incurred by it in connection with such certificates. Upon the occurrence of an Automatic Conversion of the Preferred Shares,
the Holders of such shares shall surrender the certificates representing the Preferred Shares at the office of the Corporation or any
transfer agent for the Preferred Shares. Thereupon, there shall be issued and delivered to such Holder promptly at such office, and in
its name as shown on such surrendered certificate or certificates, a certificate or certificates for the number of Conversion Shares
issuable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &ldquo;<U>Conversion
Price</U>&rdquo; means, the conversion price with respect to each Preferred Share, to be determined on the Final Closing Date, that results
in the conversion of the outstanding Preferred Stock into a number of shares of Common Stock of the Corporation that is equal to a certain
percent of the issued and outstanding shares of Common Stock (on a Fully Diluted Basis) that will be outstanding immediately following
the Spin-Out (the &ldquo;Spin-Out Capitalization&rdquo;), where the numerical value of such percent is equal to the product of (x) twenty-five
(25) and (y) the quotient of (i) the aggregate Stated Value of the issued and outstanding Preferred Shares immediately following the
Final Closing and (ii) five million (5,000,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Mechanics
of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Conversion Shares Upon Automatic Conversion</U>. Not later than two (2) Trading Days (or such earlier date as required
pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade of such Conversion Shares initiated
on the applicable Conversion Date) after each Automatic Conversion Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;), the Corporation
shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares being acquired upon the conversion
of the Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Reservation of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available
out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock, free
from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the
Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments
of <U>Section 7</U>) upon the conversion of the then outstanding Preferred Shares. The Corporation covenants that all shares of Common
Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Shares. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Conversion Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of the Preferred Shares shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such Preferred Shares and the
Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance
thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that
such tax has been paid. The Corporation shall pay all transfer agent fees required for same-day processing of any Notice of Conversion
and all fees to the Depository Trust Corporation (or another established clearing corporation performing similar functions) required
for same-day electronic delivery of the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Limitation
on Beneficial Ownership</U>. The Corporation shall not effect the conversion of any of the Preferred Shares held by a Holder, and any
such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such conversion, such
Holder, together with its other Attribution Parties collectively, would beneficially own in excess of 9.99% (the &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo;) of the shares of Common Stock outstanding immediately after giving effect to such conversion (which
provision may be waived by such Holder by written notice from such Holder to the Corporation, which notice shall be effective 61 calendar
days after the date of such notice). For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by such Holder and its other Attribution Parties shall include the number of shares of Common Stock held by such Holder and its
other Attribution Parties plus the number of shares of Common Stock issuable upon conversion of the Preferred Shares with respect to
which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (A) conversion
of the remaining, nonconverted Preferred Shares beneficially owned by such Holder or any of its other Attribution Parties and (B) exercise
or conversion of the unexercised or nonconverted portion of any other securities of the Corporation (including any convertible notes,
convertible preferred stock or warrants, including the Warrants) beneficially owned by such Holder or any other Attribution Party subject
to a limitation on conversion or exercise analogous to the limitation contained in this <U>Section 4(d)</U>. For purposes of this <U>Section
&lrm;4(d)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. For purposes of determining
the number of outstanding shares of Common Stock a Holder may acquire upon the conversion of such Preferred Shares without exceeding
the Beneficial Ownership Limitation, such Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the
Corporation&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public
filing with the SEC, as the case may be, (y) a more recent public announcement by the Corporation or (z) any other written notice by
the Corporation or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding (the &ldquo;<U>Reported
Outstanding Share Number</U>&rdquo;). If the Corporation receives a Conversion Notice from a Holder at a time when the actual number
of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Corporation shall notify such Holder in
writing of the number of shares of Common Stock then outstanding and, to the extent that such Conversion Notice would otherwise cause
such Holder&rsquo;s beneficial ownership, as determined pursuant to this <U>Section &lrm;4(d)</U>, to exceed the Beneficial Ownership
Limitation, such Holder must notify the Corporation of a reduced number of shares of Common Stock to be purchased pursuant to such Conversion
Notice. For any reason at any time, upon the written or oral request of any Holder, the Corporation shall within one (1) Business Day
confirm orally and in writing or by electronic mail to such Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Corporation, including such Preferred Shares, by such Holder and any other Attribution Party since the date as of which the Reported
Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to a Holder upon conversion of such Preferred
Shares results in such Holder and its other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Beneficial
Ownership Limitation of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number
of shares so issued by which such Holder&rsquo;s and its other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the
Beneficial Ownership Limitation (the &ldquo;<U>Excess Shares</U>&rdquo;) shall be deemed null and void and shall be cancelled ab initio,
and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the Corporation,
the Holder may from time to time increase or decrease the Beneficial Ownership Limitation to any other percentage as specified in such
notice; provided that (i) any such increase in the Beneficial Ownership Limitation will not be effective until the sixty-first (61st)
day after such notice is delivered to the Corporation and (ii) any such increase or decrease will apply only to the Holder and its other
Attribution Parties and not to any other holder of Securities that is not an Attribution Party of the Holder. For purposes of clarity,
the shares of Common Stock issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Beneficial
Ownership Limitation shall not be deemed to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d)
or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to convert such Preferred Shares pursuant to this <U>Section 4(d)</U> shall have
any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of convertibility. The
provisions of this <U>Section 4(d)</U> shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this <U>Section &lrm;4(d)</U> to the extent necessary to correct this <U>Section 4(d)</U> (or any portion thereof) which may be defective
or inconsistent with the intended beneficial ownership limitation contained in this <U>Section &lrm;4(d)</U> or to make changes or supplements
necessary or desirable to properly give effect to such limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Corporation
Redemption</U>. Notwithstanding anything to the contrary herein, after the one-year anniversary of the Initial Closing Date, and only
in the event that the Spin-Off has not occurred and the Corporation is not in material default of any of the Transaction Documents, the
Corporation may, at its option, at any time and from time to time, redeem the outstanding shares of Preferred Stock, in whole or in part,
by delivering written notice to the Holders ten (10) Trading Days prior to the date set for redemption (the &ldquo;<U>Redemption Date</U>&rdquo;).
On the Redemption Date, the Corporation will purchase the shares of Preferred Stock called for redemption (the &ldquo;<U>Redemption Shares</U>&rdquo;)
for a purchase price equal to the aggregate Stated Value of the Redemption Shares and the accrued and unpaid dividends on such Redemption
Shares (the &ldquo;<U>Redemption Price</U>&rdquo;) and each Holder shall deliver to the Corporation any certificates representing the
Redemption Shares and execute such reasonable instruments of transfer requested by the Corporation. The Redemption Price shall be payable
to the Holders by wire transfer of immediately available funds. The Corporation will not redeem any shares of Preferred Stock other than
on a pro rata basis based on the number of shares of Preferred Stock owned by each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Put
Option.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Notwithstanding
anything to the contrary herein, upon the earlier of (i) the one-year anniversary of the Initial Closing Date, and only in the event
that the Spin-Off has not occurred; or (ii) such time that the Corporation and Parent (as defined in the Securities Purchase Agreement)
have abandoned the Spin-Off (as defined in the Securities Purchase Agreement) or the Parent is no longer pursuing the Spin-Off in good
faith, the Holders shall have the right (the &ldquo;<U>Put Right</U>&rdquo;), but not the obligation, to cause the Corporation to purchase
all or a portion of the Preferred Stock for a purchase price equal to the Stated Value plus all the accrued but unpaid dividends per
share (the &ldquo;<U>Put Purchase Price</U>&rdquo;) by delivering to the Corporation a written notice exercising the Put Right (the &ldquo;<U>Put
Exercise Notice</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Mechanics</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
the Holders of Preferred Shares desire to sell any of the Preferred Shares pursuant to <U>Section 6(a)</U>, the Holders of Preferred
Shares shall deliver to the Corporation a Put Exercise Notice exercising the Put Right and specifying the number of Shares to be sold
(the &ldquo;<U>Put Shares</U>&rdquo;) by the Holders of Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) By
delivering the Put Exercise Notice, each Holder represents and warrants to the Corporation that (A) such Holder has full right, title
and interest in and to the Put Shares, (B) such Holder has all the necessary power and authority and has taken all necessary action to
sell the Preferred Shares as contemplated by this <U>Section 6</U>, and (C) the Put Shares are free and clear of any and all mortgages,
pledges, security interests, options, rights of first offer, encumbrances or other restrictions or limitations of any nature whatsoever
other than those arising as a result of or under the terms of this Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Subject
to <U>Section 6(c)</U> below, the closing of any sale of Preferred Stock pursuant to this <U>Section 6</U> shall take place no later
than twenty (20) days following receipt by the Corporation of the Put Exercise Notice. The Corporation shall give the Holders at least
five (5) days written notice of the date of closing (the &ldquo;<U>Put Right Closing Date</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Corporation will pay the Put Purchase Price for the Put Shares by wire transfer of immediately available funds on the Put Right Closing
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Corporation and the Holders each shall take all actions as may be reasonably necessary to consummate the sale contemplated by this <U>Section
6</U>, including, without limitation, entering into agreements and delivering certificates and instruments and consents as may be deemed
necessary or appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) At
the closing of any sale and purchase of Put Shares pursuant to this <U>Section 6</U>, if the Corporation shall have previously delivered
paper stock certificates, the holders of the Put Shares shall deliver to the Corporation such stock certificates (or affidavits of loss)
and an executed stock power, against receipt of the Put Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <U>Adjustment
of Conversion Price upon Subdivision or Combination of Common Stock</U>. If the Corporation at any time on or after the Subscription
Date subdivides (by any stock split, stock dividend, stock combination, recapitalization or other similar transaction) one or more classes
of its outstanding shares of Common Stock into a greater number of shares, the Conversion Price in effect immediately prior to such subdivision
will be proportionately reduced. If the Corporation at any time on or after the Subscription Date combines (by any stock split, stock
dividend, stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock
into a smaller number of shares, the Conversion Price in effect immediately prior to such combination will be proportionately increased.
Any adjustment pursuant to this <U>Section 7</U> shall become effective immediately after the effective date of such subdivision or combination.
If any event requiring an adjustment under this <U>Section 7</U> occurs during the period that a Conversion Price is calculated hereunder,
then the calculation of such Conversion Price shall be adjusted appropriately to reflect such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>Noncircumvention</U>.
The Corporation hereby covenants and agrees that the Corporation will not, by amendment of its Certificate of Incorporation, bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Certificate of Designations,
and will at all times in good faith carry out all the provisions of this Certificate of Designations and take all action as may be required
to protect the rights of the Holders. Without limiting the generality of the foregoing or any other provision of this Certificate of
Designations or the other Transaction Documents, the Corporation (a) shall not increase the par value of any shares of Common Stock receivable
upon the conversion of any Preferred Shares above the Conversion Price then in effect, (b) shall take all such actions as may be necessary
or appropriate in order that the Corporation may validly and legally issue fully paid and non-assessable shares of Common Stock upon
the conversion of Preferred Shares and (c) shall, so long as any Preferred Shares are outstanding, take all action necessary to reserve
and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the conversion of the
Preferred Shares, the maximum number of shares of Common Stock as shall from time to time be necessary to effect the conversion of the
Preferred Shares then outstanding (without regard to any limitations on conversion contained herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Reservation</U>.
So long as any Preferred Shares remain outstanding, the Corporation shall at all times reserve at least one (1) time the number of shares
of Common Stock as shall from time to time be necessary to effect the conversion of all of the Preferred Shares then outstanding and
the exercise of all warrants then outstanding (without regard to any limitations on conversions) (the &ldquo;<U>Required Reserve Amount</U>&rdquo;).
The Required Reserve Amount (including each increase in the number of shares so reserved) shall be allocated pro rata among the Holders
based on the number of the Preferred Shares held by each Holder on the Subscription Date or increase in the number of reserved shares,
as the case may be (the &ldquo;<U>Authorized Share Allocation</U>&rdquo;). In the event that a Holder shall sell or otherwise transfer
any of such Holder&rsquo;s Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder&rsquo;s Authorized
Share Allocation. Any shares of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be
allocated to the remaining Holders of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Insufficient
Authorized Shares</U>. If, notwithstanding <U>Section &lrm;9&lrm;(a)</U> and not in limitation thereof, while any of the Preferred Shares
remain outstanding the Corporation does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its
obligation to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the Required
Reserve Amount (an &ldquo;<U>Authorized Share Failure</U>&rdquo;), then the Corporation shall promptly take all actions necessary to
increase the Corporation&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Corporation to reserve the Required
Reserve Amount for the Preferred Shares then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable
after the date of an occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence of such
Authorized Share Failure, the Corporation shall hold a meeting of its stockholders for the approval of an increase in the number of authorized
shares of Common Stock. In connection with such meeting, the Corporation shall provide each stockholder with a proxy statement and shall
use its best efforts to solicit its stockholders&rsquo; approval of such increase in authorized shares of Common Stock and to cause its
Board of Directors to recommend to the stockholders that they approve such proposal. In lieu of a meeting of stockholders, the Corporation
may effect such action by written consent in accordance with Section 14(c) of the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <U>Voting
Rights</U>. Except as set forth in this Certificate of Designations or the DGCL, the Preferred Shares shall have no voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <U>Liquidation,
Dissolution, Winding-Up</U>. In the event of a Liquidation Event, the Holders shall be entitled to receive out of the assets, whether
capital or surplus, of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other
fees or damages then due and owing thereon under this Certificate of Designation, for each Preferred Share before any distribution or
payment shall be made to the holders of any Junior Stock and if the assets of the Corporation shall be insufficient to pay in full such
amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the
respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. Upon occurrence of a Liquidation
Event which is also a Fundamental Transaction, the Holders may elect to receive the rights and benefits of this <U>Section 11</U> or
the other rights set forth in the Transaction Documents. The Corporation shall mail to each Holder written notice of any such Liquidation
Event not less than twenty (20) days prior to the payment date stated therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <U>Distribution
of Assets</U>. In addition to any adjustments pursuant to <U>Section 7</U>, if the Corporation shall declare or make any dividend or
other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return
of capital or otherwise (including any distribution of cash, stock or other securities, property or options by way of a dividend, spin
off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the &ldquo;<U>Distributions</U>&rdquo;),
then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions
on the convertibility of the Preferred Shares) immediately prior to the date on which a record is taken for such Distribution or, if
no such record is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (provided,
however, that to the extent that such Holder&rsquo;s right to participate in any such Distribution would result in such Holder and its
other Attribution Parties exceeding the Beneficial Ownership Limitation, then such Holder shall not be entitled to participate in such
Distribution to the extent of the Beneficial Ownership Limitation (and shall not be entitled to beneficial ownership of such shares of
Common Stock as a result of such Distribution (and beneficial ownership) to the extent of any such excess) and the portion of such Distribution
shall be held in abeyance for such Holder until such time or times as its right thereto would not result in such Holder and its other
Attribution Parties exceeding the Beneficial Ownership Limitation, at which time or times, if any, such Holder shall be granted such
rights (and any rights under this <U>Section &lrm;12</U> on such initial rights or on any subsequent such rights to be held similarly
in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <U>Vote
to Change the Terms of or Issue Preferred Shares</U>. Except as may be provided for in the Securities Purchase Agreement, and in addition
to any other rights provided by law, except where the vote or written consent of the holders of a greater number of shares is required
by law or by another provision of the Certificate of Incorporation, without first obtaining the affirmative vote at a meeting duly called
for such purpose or the written consent without a meeting of the Required Holders, voting together as a single class, the Corporation
shall not: (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation or bylaws, or file any certificate
of designations or articles of amendment of any series of shares of preferred stock, if such action would adversely alter or change in
any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit, of the Preferred Shares, regardless
of whether any such action shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation or otherwise;
(b) increase or decrease (other than by conversion) the authorized number of Preferred Shares; (c) without limiting any provision of
<U>Section &lrm;1</U>, create or authorize (by reclassification or otherwise) any new class or series of shares that has a preference
over, or on a parity with, the Preferred Shares with respect to dividends or the distribution of assets on the liquidation, dissolution
or winding up of the Corporation; (d) purchase, repurchase or redeem any shares of capital stock of the Corporation junior in rank to
the Preferred Shares ; (e) without limiting any provision herein, pay dividends or make any other distribution on any shares of any capital
stock of the Corporation junior in rank to the Preferred Shares; (f) issue any Preferred Shares or preferred stock other than in compliance
with the terms of this Certificate of Designations; or (g) without limiting any provision of <U>Sections &lrm;7</U> and <U>8</U>, whether
or not prohibited by the terms of the Preferred Shares, circumvent a right of the Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <U>Transfer
of Preferred Shares</U>. A Holder may not transfer some or all of its Preferred Shares without the consent of the Corporation except
to an Affiliate. This restriction is subject to Purchaser approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <U>Reissuance
of Preferred Certificates</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Transfer</U>.
If any Preferred Shares are to be transferred in accordance with the terms hereof, the applicable Holder shall surrender the applicable
Preferred Share Certificate to the Corporation, whereupon the Corporation will forthwith issue and deliver upon the order of such Holder
a new Preferred Share Certificate (in accordance with <U>Section 15(d)</U>), registered as such Holder may request, representing the
outstanding number of Preferred Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred
Shares is being transferred, a new Preferred Share Certificate (in accordance with <U>Section 15(d)</U>) to such Holder representing
the outstanding number of Preferred Shares not being transferred. Such Holder and any assignee, by acceptance of the Preferred Share
Certificate, acknowledge and agree that, by reason of the provisions of <U>Section 4</U> following conversion or redemption of any of
the Preferred Shares, the outstanding number of Preferred Shares represented by the Preferred Shares may be less than the number of Preferred
Shares stated on the face of the Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Lost,
Stolen or Mutilated Preferred Share Certificate</U>. Upon receipt by the Corporation of evidence reasonably satisfactory to the Corporation
of the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification
contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking
by the applicable Holder to the Corporation in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of such Preferred Share Certificate, the Corporation shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance
with <U>Section 15(d)</U>) representing the applicable outstanding number of Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Preferred
Share Certificate Exchangeable for Different Denominations</U>. Each Preferred Share Certificate is exchangeable, upon the surrender
hereof by the applicable Holder at the principal office of the Corporation, for a new Preferred Share Certificate or Preferred Share
Certificate(s) (in accordance with <U>Section 15(d)</U>) representing in the aggregate the outstanding number of the Preferred Shares
in the original Preferred Share Certificate, and each such new certificate will represent such portion of such outstanding number of
Preferred Shares from the original Preferred Share Certificate as is designated by such Holder at the time of such surrender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Issuance
of New Preferred Share Certificate</U>. Whenever the Corporation is required to issue a new Preferred Share Certificate pursuant to the
terms of this Certificate of Designations, such new Preferred Share Certificate (i) shall represent, as indicated on the face of such
Preferred Share Certificate, the number of Preferred Shares remaining outstanding (or in the case of a new Preferred Share Certificate
being issued pursuant to <U>Section 15(a)</U> or <U>Section 15(c)</U>, the number of Preferred Shares designated by such Holder which,
when added to the number of Preferred Shares represented by the other new Preferred Share Certificates issued in connection with such
issuance, does not exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate immediately
prior to such issuance of new Preferred Share Certificate), and (ii) shall have an issuance date, as indicated on the face of such new
Preferred Share Certificate, which is the same as the issuance date of the original Preferred Share Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16. <U>Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief.</U> The remedies provided in this Certificate of Designations shall
be cumulative and in addition to all other remedies available under this Certificate of Designations and any of the other Transaction
Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit any Holder&rsquo;s right to pursue actual and consequential damages for any failure by the Corporation to comply with the terms
of this Certificate of Designations. The Corporation covenants to each Holder that there shall be no characterization concerning this
instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion and
the like (and the computation thereof) shall be the amounts to be received by a Holder and shall not, except as expressly provided herein,
be subject to any other obligation of the Corporation (or the performance thereof). The Corporation acknowledges that a breach by it
of its obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for any such breach may be inadequate.
The Corporation therefore agrees that, in the event of any such breach or threatened breach, each Holder shall be entitled, in addition
to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief
from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond
or other security. The Corporation shall provide all information and documentation to a Holder that is requested by such Holder to enable
such Holder to confirm the Corporation&rsquo;s compliance with the terms and conditions of this Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17. <U>Payment
of Collection, Enforcement and Other Costs</U>. If (a) any Preferred Shares are placed in the hands of an attorney for collection or
enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under
this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations
or (b) there occurs any bankruptcy, reorganization, receivership of the Corporation or other proceedings affecting Corporation creditors&rsquo;
rights and involving a claim under this Certificate of Designations, then the Corporation shall pay the costs incurred by such Holder
for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including
attorneys&rsquo; fees and disbursements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18. <U>Construction;
Headings</U>. This Certificate of Designations shall be deemed to be jointly drafted by the Corporation and the Holders and shall not
be construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference
and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise,
each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo;
&ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed broadly as if followed by the words &ldquo;without
limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this
entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section
references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined
herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Closing Date in such other
Transaction Documents unless otherwise consented to in writing by the Required Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19. <U>Failure
or Indulgence Not Waiver</U>. No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by the Corporation and all
Holders and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this
<U>Section &lrm;19</U> shall permit any waiver of any provision of <U>Section 17</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20. <U>Notices;
Currency; Payments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Notices</U>.
The Corporation shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of
this Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice
is required to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and
shall be given in accordance with <U>Section 9(f)</U> of the Securities Purchase Agreement. The Corporation shall provide each Holder
with prompt written notice of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description
of such action and the reason therefore. Without limiting the generality of the foregoing, the Corporation shall give written notice
to each Holder (i) immediately upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation
of such adjustment and (ii) at least fifteen (15) days prior to the date on which the Corporation closes its books or takes a record
(A) with respect to any dividend or distribution upon the Common Stock, (B) with respect to any grant, issuances, or sales of any Options,
Convertible Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C)
for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such
information shall be made known to the public prior to or in conjunction with such notice being provided to such Holder. Notwithstanding
the foregoing, the Corporation shall not be required to deliver any notice that may contain material non-public information, if the Corporation
has not made public disclosure thereof in accordance with applicable law and the Corporation believes that public disclosure would be
pre-mature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Currency</U>.
All dollar amounts referred to in this Certificate of Designations are in United States Dollars (&ldquo;<U>U.S. Dollars</U>&rdquo;),
and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies
(if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &ldquo;<U>Exchange
Rate</U>&rdquo; means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,
the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed
that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such
period of time).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Payments</U>.
Whenever any payment of cash is to be made by the Corporation to any Person pursuant to this Certificate of Designations, unless otherwise
expressly set forth herein, such payment shall be made in lawful money of the United States of America by a certified check drawn on
the account of the Corporation and sent via overnight courier service to such Person at such address as previously provided to the Corporation
in writing (which address, in the case of each of the Buyers (as defined in the Securities Purchase Agreement), shall initially be as
set forth on the Schedule of Buyers attached to the Securities Purchase Agreement); provided, that such Holder may elect to receive a
payment of cash via wire transfer of immediately available funds by providing the Corporation with prior written notice setting out such
request and such Holder&rsquo;s wire transfer instructions. Whenever any amount expressed to be due by the terms of this Certificate
of Designations is due on any day which is not a Business Day, the same shall instead be due on the next succeeding day which is a Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21. <U>Waiver
of Notice</U>. To the extent permitted by law, the Corporation hereby irrevocably waives demand, notice, presentment, protest and all
other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations
and the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22. <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations shall
be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles
of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the
transactions contemplated hereby (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders,
employees or agents) shall be commenced in the state or federal courts located in the State and County of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23. <U>Severability</U>.
If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a
court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to
apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not
affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so
modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24. <U>Stockholder
Matters; Amendment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Stockholder
Matters</U>. Any stockholder action, approval or consent required, desired or otherwise sought by the Corporation pursuant to the DGCL,
the Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may
be effected by written consent of the Corporation&rsquo;s stockholders or at a duly called meeting of the Corporation&rsquo;s stockholders,
all in accordance with the applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections
of the DGCL permitting stockholder action, approval and consent affected by written consent in lieu of a meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Amendment</U>.
This Certificate of Designations or any provision hereof (other than <U>Section 4(d)</U>) may be modified or amended or the provisions
hereof waived with the written consent of the Corporation and the Required Holders. No consideration (other than reimbursement of legal
fees) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction
Documents (as defined in the Securities Purchase Agreement) unless the same consideration also is offered to all of the parties to the
Transaction Documents. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving
party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25. <U>Certain
Defined Terms</U>. For purposes of this Certificate of Designations, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &ldquo;<U>1934
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &ldquo;<U>Affiliate</U>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo; of a Person means the power directly
or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of directors of such Person or direct
or cause the direction of the management and policies of such Person whether by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &ldquo;<U>Attribution
Parties</U>&rdquo; means, with respect to a Holder, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Subscription Date, directly or indirectly managed
or advised by such Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of
such Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder
or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Corporation&rsquo;s Common Stock would or could
be aggregated with such Holder&rsquo;s and its other Attribution Parties&rsquo; for purposes of Section 13(d) of the 1934 Act. For clarity,
the purpose of the foregoing is to subject collectively such Holder and its other Attribution Parties to the Beneficial Ownership Limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an
individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the 1934 Act) of effective control
(whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of fifty percent
(50%) of the voting securities of the Corporation, (b) the Corporation merges into or consolidates with any other Person, or any Person
merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately
prior to such transaction own less than fifty percent (50%) of the aggregate voting power of the Corporation or the successor entity
of such transaction, or (c) the Corporation disposes of all or substantially all of its assets to another Person and the stockholders
of the Corporation immediately prior to such transaction own less than fifty percent (50%) of the aggregate voting power of the acquiring
entity immediately after the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &ldquo;<U>Common
Stock</U>&rdquo; means (i) the Corporation&rsquo;s shares of common stock, $0.01 par value per share, and (ii) any capital stock into
which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &ldquo;<U>Common
Stock Equivalents</U>&rdquo; means those securities identified and defined as such in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &ldquo;<U>Excluded
Securities</U>&rdquo; means those securities identified and defined as such in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &ldquo;<U>Final
Closing Date</U>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Corporation
issued Preferred Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &ldquo;<U>Fully
Diluted Basis</U>&rdquo; shall mean the assumption that all options, warrants or other convertible securities or instruments or other
rights to acquire Common Stock or any other existing or future classes of capital stock have been exercised or converted, as applicable,
in full, regardless of whether any such options, warrants, convertible securities or instruments or other rights are then vested or exercisable
or convertible in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &ldquo;<U>Group</U>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means a holder of Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &ldquo;<U>Initial
Closing Date</U>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Corporation
initially issued the Preferred Shares pursuant to the terms of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &ldquo;<U>Liquidation
Event</U>&rdquo; means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution
or winding up of the Corporation or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business
of the Corporation and its Subsidiaries, taken as a whole, or a Change of Control Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &ldquo;<U>Options</U>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) &ldquo;<U>Person</U>&rdquo;
means an individual, a limited liability Corporation, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) &ldquo;<U>Principal
Market</U>&rdquo; means The New York Stock Exchange, the NYSE MKT, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq
Capital Market, OTCPink, OTCQB, or OTCQX and any successor markets thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &ldquo;<U>SEC</U>&rdquo;
means the Securities and Exchange Commission or the successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &ldquo;<U>Securities
Purchase Agreement</U>&rdquo; means that certain securities purchase agreement by and among the Corporation and the holders of Preferred
Shares, dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &ldquo;<U>Stated
Value</U>&rdquo; shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations,
reclassifications, combinations, subdivisions or other similar events occurring after the Subscription Date with respect to the Preferred
Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) &ldquo;<U>Subscription
Date</U>&rdquo; with respect to any Holder means the date as of which both the Holder and the Corporation have executed the Securities
Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &ldquo;<U>Subsidiary</U>&rdquo;,
when used with respect to any Person, means any corporation or other organization, whether incorporated or unincorporated, of which (a)
at least a majority of the securities or other interests having by their terms ordinary voting power to elect a majority of the board
of directors or others performing similar functions with respect to such corporation or other organization is directly or indirectly
owned or controlled by such Person (through ownership of securities, by contract or otherwise) or (b) such Person or any subsidiary of
such Person is a general partner of any general partnership or a manager of any limited liability company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) &ldquo;<U>Trading
Day</U>&rdquo; means any day on which the Common Stock is eligible to be traded on the Principal Market or securities market on which
the Common Stock is then traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled
to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final
hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on
such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading
Day in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) &ldquo;<U>Transaction
Documents</U>&rdquo; means the Securities Purchase Agreement, this Certificate of Designations, the RRA (as defined in the Securities
Purchase Agreement), the Warrants and each of the other agreements and instruments entered into or delivered by the Corporation or any
of the Holders in connection with the transactions contemplated by the Securities Purchase Agreement, all as may be amended from time
to time in accordance with the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) &ldquo;<U>Warrants</U>&rdquo;
has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor
or replacement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Certificate of Designations of Series A Convertible Preferred Stock of Acanna Therapeutics,
Inc. to be signed by its Chief Executive Officer and Secretary on this 4th day of May, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Acanna
    Therapeutics, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Joseph Tucker</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Tucker,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of [__], 2022, between Acanna Therapeutics,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser,
a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement.</B> As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the Spin-Off Date and with
respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 60<SUP>th</SUP>
calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of
a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following the date such additional Registration Statement
is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that
one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness
Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such
date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading
Day, then the Effectiveness Date shall be the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, on such date that the Company files a registration
statement with the Securities and Exchange Commission in connection with the Spin-Off, and, with respect to any additional Registration
Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which the Company is permitted
by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all of the Conversion Shares, (b) all Warrant Shares issued and issuable
upon exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein),
(c) Warrants issued and issuable to the Placement Agent as further described on Schedule 3(g) of the Purchase Agreement, (d) Common Stock
issued and issuable to the Advisor as further identified on Schedule 3(g) of the Purchase Agreement, (e) all other shares of Common Stock
issued pursuant to the Transaction Documents which have been, or which may, from time to time be issued or become issuable to the Purchasers
under the Transaction Documents (without regard to any limitation or restriction on Purchasers), and (f) any securities issued or then
issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; <U>provided,
however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to
maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration
Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and
such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable
Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or
manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such
effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities
issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were
at no time held by any Affiliate of the Company, and all Warrants are exercised by &ldquo;cashless exercise&rdquo; as provided in Section
1(f) of each of the Warrants), as reasonably determined by the Company, upon the advice of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Shelf Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of
all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a
continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85%
in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially
the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder
shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent. Subject to the
terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including,
without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof,
but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement
continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement
(i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to
Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144,
as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer
Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;). In any event, with respect to Section 2(a)(ii), the Effectiveness
Period will continue until a registration statement has been effective for 180 days, which need not be consecutive. The Company shall
telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall
immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that
the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration
Statement. The Company shall, by 9:30 a.m. (New York City time) on the second (2<SUP>nd</SUP>) Trading Day after the effective date of
such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder within
one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event
under Section 2(d).</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the
provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the
Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or
any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
                                            the Company shall reduce or eliminate any securities to be included other than Registrable
                                            Securities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
                                            the Company shall reduce Registrable Securities represented by Warrant Shares issuable in
                                            connection with the exercise of the Series B Warrants (applied, in the case that some Warrant
                                            Shares may be registered, to the Holders on a pro rata basis based on the total number of
                                            unregistered Warrant Shares held by such Holders); and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third,
                                            the Company shall reduce Registrable Securities represented by Warrant Shares issuable in
                                            connection with the exercise of the Series A Warrants (applied, in the case that some Conversion
                                            Shares may be registered, to the Holders on a pro rata basis based on the total number of
                                            unregistered Conversion Shares held or acquirable upon conversion of the Preferred Stock
                                            by such Holders).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) If:
(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement
without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall
be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of
a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading
Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement
will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) a Registration Statement registering for resale
all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement,
or (iv) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously
effective as to all Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize
the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate
of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being
referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for
purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which
such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar
day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the
Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if
the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder
an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate Subscription
Amount paid by such Holder pursuant to the Purchase Agreement up to a maximum of 12%. If the Company fails to pay any partial liquidated
damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of
18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date
such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated
damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) If
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as
any Underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Registration Procedures</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the
filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Required Holders of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified
of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration Statement
or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto.
Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex B</U> (a &ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of
the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by
an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Use
its reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the
effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the
Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account
the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of
the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j)
to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise
required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Otherwise
use best efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act,
including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof,
with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during the
Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required
to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably
necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) The
Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of
the resale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable
Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any
liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely
because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Registration Expenses</U>. All fees and expenses incident to the performance of or compliance
with, this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration
Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing
fees (including, without limitation, fees and expenses of the Company&rsquo;s counsel and independent registered public accountants)
(A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which
the Common Stock is then listed for trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed
to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue
Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing
certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for
the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other
Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition,
the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated
by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting
duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities
on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions
of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the
officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as
a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other
Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally
equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person,
to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, arising
out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the
case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation
or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder,
in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such
untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder
expressly for use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution
of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement,
such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose)
or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated,
defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated,
defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section
6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection
with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect
regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities
by any of the Holders in accordance with Section 6(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents
and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Stockholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by
such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by
such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by
a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially
and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Contribution</U>.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made
by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party
as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo;
or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Remedies</U>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including
recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder
agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the
provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach,
it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security holders
(other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other
than the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of
the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition
of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the
Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use
its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by
the Company and the Required Holders (as defined in the Purchase Agreement) or more of the then outstanding Registrable Securities (for
purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that,
if any amendment, modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such
disproportionately impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the
Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable
Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate
which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent
to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and
that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable
Securities to which such waiver or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be
amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6(d). No consideration
shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the
same consideration also is offered to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their
respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would
have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except
as set forth on <U>Schedule 6(g)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting
any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other
kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect
to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action
or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do
so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a
Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Acanna
    Therapeutics, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO Acanna Therapeutics, Inc. RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _________________________</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
of Distribution</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales made after the effective date of the Registration Statement;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated
    price per security;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling shareholders are those being issued to the selling shareholders pursuant to the Purchase Agreement,
and those issuable to the selling shareholders, upon exercise of the warrants. For additional information regarding the issuances of
those shares of common stock and warrants, see &ldquo;Private Placement of Series A Convertible Preferred Stock and Warrants&rdquo; above.
We are registering the shares of common stock in order to permit the selling shareholders to offer the shares for resale from time to
time. Except for the ownership of the shares of common stock and the warrants, the selling shareholders have not had any material relationship
with us within the past three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by
each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by each selling shareholder,
based on its ownership of the shares of common stock and warrants, as of ________, 2022, assuming exercise of the warrants held by the
selling shareholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement of Series A
Convertible Preferred Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of common stock issuable upon exercise
of the related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding
the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable
date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations
on the exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant
to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants, a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder,
together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 9.99%
of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable
upon exercise of the warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect this
limitation. The selling shareholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><BR STYLE="clear: both">
    </B><BR>
    <B><BR>
    Name of Selling Shareholder</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of Common Stock Owned After Offering</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Number of shares of Common Stock to be Sold Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of Common Stock Owned After Offering</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acanna
Therapeutics, Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Stockholder Notice and Questionnaire</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of [SPINCO], a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration
and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities,
in accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth
below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable
Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONNAIRE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Name.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Selling Stockholder</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote
    or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Address for Notices to Selling Stockholder:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Person:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
Broker-Dealer Status:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    you a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to
    the Company?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
    Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    you an affiliate of a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business,
    and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or
    indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
    Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than
the securities issuable pursuant to the Purchase Agreement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    and Amount of other securities beneficially owned by the Selling Stockholder:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
Relationships with the Company:</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
    any exceptions here:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Owner: </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO
THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT
MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">1(a)
<FONT STYLE="text-transform: uppercase">OF THIS WARRANT.</FONT></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">Acanna
Therapeutics, Inc.</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
To Purchase Common Stock</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
No.: [___]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: [____] (&ldquo;<U>Issuance Date</U>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acanna
Therapeutics, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [_______], the registered holder hereof or its permitted assigns (the &ldquo;<U>Holder</U>&rdquo;),
is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer
or replacement hereof, the &ldquo;<U>Warrant</U>&rdquo;), at any time or times on or after the Spin-Off Date (as defined below) (the
&ldquo;<U>Initial Exercisability Date</U>&rdquo;), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below),
[______]<SUP>1</SUP> (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below)
(the &ldquo;<U>Warrant Shares</U>&rdquo;, and such number of Warrant Shares, the &ldquo;<U>Warrant Number</U>&rdquo;). Except as otherwise
defined herein, capitalized terms in this Warrant shall have the meanings set forth in <U>Section 16</U>. This Warrant is one of the
Warrants to Purchase Common Stock (the &ldquo;<U>SPA Warrants</U>&rdquo;) issued pursuant to Section 1 of that certain Securities Purchase
Agreement, dated as of May 5, 2022, by and among the Company and the investors (the &ldquo;<U>Buyers</U>&rdquo;) referred to therein,
as amended from time to time (the &ldquo;<U>Securities Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP> 100% of the shares of Common Stock issuable upon conversion of the Preferred Stock such buyer purchased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">1. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXERCISE
OF WARRANT.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in <U>Section 1(d)</U>),
this Warrant may be exercised by the Holder on any day on or after the Initial Exercisability Date (an &ldquo;<U>Exercise Date</U>&rdquo;),
in whole or in part, by delivery (whether via facsimile or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit
A</U></B> (the &ldquo;<U>Exercise Notice</U>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading
Day following an exercise of this Warrant as aforesaid, the Holder shall deliver payment to the Company of an amount equal to the Exercise
Price in effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant was so exercised (the
&ldquo;<U>Aggregate Exercise Price</U>&rdquo;) in cash or via wire transfer of immediately available funds. The Holder shall not be required
to deliver the original of this Warrant in order to effect an exercise hereunder unless no Warrant Shares are issuable thereafter. Execution
and delivery of an Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of
the original of this Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. Execution
and delivery of an Exercise Notice for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original
of this Warrant after delivery of the Warrant Shares in accordance with the terms hereof. On or before the second (2<SUP>nd</SUP>) Trading
Day following the date on which the Company has received an Exercise Notice, the Company shall transmit by facsimile or electronic mail
an acknowledgment of confirmation of receipt of such Exercise Notice, in the form attached hereto as <B><U>Exhibit B</U></B>, to the
Holder and the Company&rsquo;s transfer agent (the &ldquo;<U>Transfer Agent</U>&rdquo;), which confirmation shall constitute an instruction
to the Transfer Agent to process such Exercise Notice in accordance with the terms herein. On or before the second (2<SUP>nd</SUP> )
Trading Day following the date on which the Company has received such Exercise Notice (or such earlier date as required pursuant to the
1934 Act or other applicable law, rule or regulation for the settlement of a trade of such Warrant Shares initiated on the applicable
Exercise Date), the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;)
Fast Automated Securities Transfer Program and there is an effective registration covering the resale of the Warrant Shares by the Holder,
upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such
exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian system, or
(Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or the there is no effective registration
statement covering the resale of the Warrant Shares by the Holder, issue and deliver (via reputable overnight courier) to the address
as specified in the Exercise Notice, a certificate, registered in the name of the Holder or its designee, for the number of shares of
Common Stock to which the Holder shall be entitled pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder shall be
deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the
certificates evidencing such Warrant Shares (as the case may be). If this Warrant is submitted in connection with any exercise pursuant
to this <U>Section 1(a)</U> and the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number
of Warrant Shares being acquired upon an exercise and upon surrender of this Warrant to the Company by the Holder, then, at the request
of the Holder, the Company shall as soon as practicable and in no event later than three (3) Business Days after any exercise and at
its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance with <U>Section 7(d)</U>) representing
the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number
of Warrant Shares with respect to which this Warrant is exercised. No fractional shares of Common Stock are to be issued upon the exercise
of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company
shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses
of the Transfer Agent) that may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant.
The Company&rsquo;s failure to deliver Warrant Shares to the Holder on or prior to the later of (i) second (2<SUP>nd</SUP>) Trading Days
after receipt of the applicable Exercise Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule
or regulation for the settlement of a trade of such Warrant Shares initiated on the applicable Exercise Date) and (ii) one (1) Trading
Day after the Company&rsquo;s receipt of the Aggregate Exercise Price (such later date, the &ldquo;<U>Share Delivery Date</U>&rdquo;)
shall be deemed to be a breach of this Warrant. Notwithstanding anything to the contrary contained in this Warrant, after the effective
date of a registration statement registering for resale any Warrant Shares issuable hereunder and prior to the Holder&rsquo;s receipt
of notice that such registration statement is no longer available, the Company shall cause the Transfer Agent to deliver unlegended shares
of Common Stock to the Holder (or its designee) in connection with any sale of Warrant Shares with respect to which the Holder has entered
into a contract for sale, and delivered a copy of the prospectus included as part of the particular registration statement to the extent
applicable, and for which the Holder has not yet settled. From the Issuance Date through and including the Expiration Date, the Company
shall maintain a transfer agent that participates in the DTC&rsquo;s Fast Automated Securities Transfer Program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<U>Exercise Price</U>&rdquo; means [____]<SUP>2</SUP>, subject to adjustment as provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If the Company shall fail, for any reason or for no reason, on or prior to the Share Delivery
Date, if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, to issue and deliver to the Holder
(or its designee) a certificate for the number of Warrant Shares to which the Holder is entitled and register such Warrant Shares on
the Company&rsquo;s share register or, if the Transfer Agent is participating in the DTC Fast Automated Securities Transfer Program,
to credit the balance account of the Holder or the Holder&rsquo;s designee with DTC for such number of Warrant Shares to which the Holder
is entitled upon the Holder&rsquo;s exercise of this Warrant (as the case may be) (a &ldquo;<U>Delivery Failure</U>&rdquo;), then, in
addition to all other remedies available to the Holder, (X) the Company shall pay in cash to the Holder on each day after the Share Delivery
Date and during such Delivery Failure an amount equal to 1% of the product of (A) the number of shares of Common Stock not issued to
the Holder on or prior to the Share Delivery Date and to which the Holder is entitled, multiplied by (B) the great of (i) the Exercise
Price; or (ii) any trading price of the Common Stock selected by the Holder in writing as in effect at any time during the period beginning
on the applicable Exercise Date and ending on the actual delivery of the Warrant Shares, and (Y) the Holder, upon written notice to the
Company, may void its Exercise Notice with respect to, and retain or have returned, as the case may be, any portion of this Warrant that
has not been exercised pursuant to such Exercise Notice; provided that the voiding of an Exercise Notice shall not affect the Company&rsquo;s
obligations to make any payments which have accrued prior to the date of such notice pursuant to this <U>Section 1(c)</U> or otherwise.
In addition to the foregoing, if on or prior to the Share Delivery Date the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program, the Company shall fail to issue and deliver to the Holder (or its designee) a certificate and register such
shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in the DTC Fast Automated Securities
Transfer Program, the Transfer Agent shall fail to credit the balance account of the Holder or the Holder&rsquo;s designee with DTC for
the number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s
obligation pursuant to clause (ii) below, and if on or after such Share Delivery Date the Holder purchases (in an open market transaction
or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock issuable upon such exercise
that the Holder is entitled to receive from the Company and has not received from the Company in connection with such Delivery Failure
or Notice Failure, as applicable (a &ldquo;<U>Buy-In</U>&rdquo;), then, in addition to all other remedies available to the Holder, the
Company shall, within three (3) Business Days after the Holder&rsquo;s request and in the Holder&rsquo;s discretion, either (i) pay cash
to the Holder in an amount equal to the Holder&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the shares of Common Stock so purchased (including, without limitation, by any other Person in respect, or on behalf,
of the Holder) (the &ldquo;<U>Buy-In Price</U>&rdquo;), at which point the Company&rsquo;s obligation to so issue and deliver such certificate
(and to issue such shares of Common Stock) or credit the balance account of such Holder or such Holder&rsquo;s designee, as applicable,
with DTC for the number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder (as the case may
be) (and to issue such Warrant Shares) shall terminate, or (ii) promptly honor its obligation to so issue and deliver to the Holder a
certificate or certificates representing such Warrant Shares or credit the balance account of such Holder or such Holder&rsquo;s designee,
as applicable, with DTC for the number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder (as
the case may be) and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such
number of Warrant Shares multiplied by (B) the lowest Closing Sale Price of the Common Stock on any Trading Day during the period commencing
on the date of the applicable Exercise Notice and ending on the date of such issuance and payment under this clause (ii) (the &ldquo;<U>Buy-In
Payment Amount</U>&rdquo;). Nothing shall limit the Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law
or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock)
upon the exercise of this Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>The exercise price will be equal to [110% of the post-Spin-Off valuation price]/[125% of the post-Spin-Off valuation
price]</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Limitations
on Exercises</U>. The Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to
exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void
and treated as if never made, to the extent that after giving effect to such exercise, the Holder together with the other Attribution
Parties collectively would beneficially own in excess of 4.99% (the &ldquo;<U>Maximum Percentage</U>&rdquo;) of the shares of Common
Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares
of Common Stock beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock
held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant
with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable
upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution
Parties and (B) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without
limitation, any convertible notes or convertible preferred stock or warrants, including other SPA Warrants) beneficially owned by the
Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this
<U>Section 1(d)</U>. For purposes of this <U>Section 1(f)</U>, beneficial ownership shall be calculated in accordance with Section 13(d)
of the 1934 Act. For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise
of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as
reflected in (x) the Company&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K
or other public filing with the SEC, as the case may be, (y) a more recent public announcement by the Company or (z) any other written
notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding (the &ldquo;<U>Reported
Outstanding Share Number</U>&rdquo;). If the Company receives an Exercise Notice from the Holder at a time when the actual number of
outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i) notify the Holder in writing
of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&rsquo;s
beneficial ownership, as determined pursuant to this <U>Section 1(d)</U>, to exceed the Maximum Percentage, the Holder must notify the
Company of a reduced number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by which such purchase
is reduced, the &ldquo;<U>Reduction Shares</U>&rdquo;) and (ii) as soon as reasonably practicable, the Company shall return to the Holder
any exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the Holder,
the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to the Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since
the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to
the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in
the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d)
of the 1934 Act), the number of shares so issued by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial
ownership exceeds the Maximum Percentage (the &ldquo;<U>Excess Shares</U>&rdquo;) shall be deemed null and void and shall be cancelled
ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after
the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid by the
Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from time to time increase (with such
increase not effective until the sixty-first (61<SUP>st</SUP>) day after delivery of such notice) or decrease the Maximum Percentage
to any other percentage as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective
until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company and (ii) any such increase or decrease will
apply only to the Holder and the other Attribution Parties and not to any other holder of SPA Warrants that is not an Attribution Party
of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum
Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule
16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section 1(d)</U> to the
extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended
beneficial ownership limitation contained in this <U>Section 1(d)</U> or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Reservation
of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Required
Reserve Amount</U>. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance under this
Warrant a number of shares of Common Stock at least equal to one (1) times the maximum number of shares of Common Stock as shall be necessary
to satisfy the Company&rsquo;s obligation to issue shares of Common Stock under the SPA Warrants then outstanding (without regard to
any limitations on exercise) (the &ldquo;<U>Required Reserve Amount</U>&rdquo;); provided that at no time shall the number of shares
of Common Stock reserved pursuant to this <U>Section 1(e)(i)</U> be reduced other than proportionally in connection with (i) any exercise
or redemption of SPA Warrants or such other event covered by <U>Section 2(a)</U> below, or (ii) upon an exercise of a Warrant, the shares
reserved shall be reduced by the same number of Warrant Shares issued. The Required Reserve Amount (including, without limitation, each
increase in the number of shares so reserved) shall be allocated pro rata among the holders of the SPA Warrants based on number of shares
of Common Stock issuable upon exercise of SPA Warrants held by each holder on the Final Closing Date (without regard to any limitations
on exercise) or increase in the number of reserved shares, as the case may be (the &ldquo;<U>Authorized Share Allocation</U>&rdquo;).
In the event that a Holder shall sell or otherwise transfer any of such holder&rsquo;s SPA Warrants, each transferee shall be allocated
a pro rata portion of such Holder&rsquo;s Authorized Share Allocation. Any shares of Common Stock reserved and allocated to any Person
which ceases to hold any SPA Warrants shall be allocated to the remaining holders of SPA Warrants, pro rata based on the number of shares
of Common Stock issuable upon exercise of the SPA Warrants then held by such holders (without regard to any limitations on exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Insufficient
Authorized Shares</U>. If, notwithstanding <U>Section 1(e)(i) above</U>, and not in limitation thereof, at any time while any of the
SPA Warrants remain outstanding, the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to
satisfy its obligation to reserve the Required Reserve Amount (an &ldquo;<U>Authorized Share Failure</U>&rdquo;), then the Company shall
immediately take all actions necessary to increase the Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow
the Company to reserve the Required Reserve Amount for all the SPA Warrants then outstanding. Without limiting the generality of the
foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than
ninety (90) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the
approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide
each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders&rsquo; approval of such increase in
authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal.
In the event that the Company is prohibited from issuing shares of Common Stock upon an exercise of this Warrant due to the failure by
the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common Stock (such unavailable
number of shares of Common Stock, the &ldquo;<U>Authorization Failure Shares</U>&rdquo;), in lieu of delivering such Authorization Failure
Shares to the Holder, the Company shall pay cash in exchange for the cancellation of such portion of this Warrant exercisable into such
Authorization Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorization Failure Shares and (y)
the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date the Holder delivers the
applicable Exercise Notice with respect to such Authorization Failure Shares to the Company and ending on the date of such issuance and
payment under this <U>Section 1(d)</U>; and (ii) to the extent the Holder purchases (in an open market transaction or otherwise) shares
of Common Stock to deliver in satisfaction of a sale by the Holder of Authorization Failure Shares, any Buy-In Payment Amount, brokerage
commissions and other out-of-pocket expenses, if any, of the Holder incurred in connection therewith. Nothing contained in this <U>Section
1(e)</U> shall limit any obligations of the Company under any provision of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Cashless
Exercise</U>. If as of the date of the delivery of a Exercise Notice: (i) there is no effective registration statement (&ldquo;Registration
Statement&rdquo;) under the Securities Act registering, or no current prospectus available for the resale of the Warrant Shares by the
Holder; and (2) the VWAP (as defined below) of one share of Common Stock is greater than the Exercise Price in effect at such time, then
this Warrant may also be exercised at the Holder&rsquo;s election, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a &ldquo;cashless
exercise,&rdquo; as set forth in the applicable Notice of Exercise;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, unless the Holder notifies the Company otherwise, if there is no effective
Registration Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this
Warrant shall be automatically exercised via cashless exercise pursuant to this Section..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;VWAP&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the principal Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. to 4:02 p.m., (b) if any of the NASDAQ markets or exchanges is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed
or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported on the OTCQX, OTCQB or OTC Pink
Marketplace maintained by the OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices),
the volume weighted average price of the Common Stock on the first such facility (or a similar organization or agency succeeding to its
functions of reporting prices), or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">2. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. <FONT STYLE="text-transform: none">The Exercise Price and number of Warrant Shares
issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this <U>Section</U></FONT><U> 2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 2(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Reserved.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to this <U>Section 2</U>, the number of Warrant
Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment
the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise
Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Calculations</U>.
All calculations under this <U>Section 2</U> shall be made by rounding to the nearest cent or the nearest 1/100<SUP>th</SUP> of a share,
as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the
account of the Company, and the disposition of any such shares shall be considered an issuance or sale of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Voluntary
Adjustment By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of the Required
Holders (as defined in the Securities Purchase Agreement), reduce the then current Exercise Price to any amount and for any period of
time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">3. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RESERVED.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">4. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Purchase
Rights</U>. In addition to any adjustments pursuant to <U>Section 2</U> above, if at any time the Company grants, issues or sells any
Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of
any class of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this
Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the grant, issuance or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties
exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to the extent of the Maximum
Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right (and
beneficial ownership) to the extent of any such excess) and such Purchase Right to such extent shall be held in abeyance for the benefit
of the Holder until such time or times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties
exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued
or sold on such initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance) to the same extent as if there
had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Fundamental
Transactions</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any Fundamental Transaction (as defined below), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in <U>Section 2(e)</U> on the exercise
of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the &ldquo;Alternate Consideration&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental
Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For purposes of any such exercise,
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount
of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise
of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction contemplated
by clause (f) of the definition thereof in which the Company is not the survivor (the &ldquo;Successor Entity&rdquo;) to assume in writing
all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this
<U>Section 4(b)</U> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. For purposes hereof, &ldquo;<U>Fundamental
Transaction</U>&rdquo; means, excluding the Spin-Off (as defined below), the occurrence after the date hereof of any of (a) an acquisition
after the date hereof by an individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d 5(b)(1) promulgated under the
Exchange Act), other than a legal entity majority owned by, or a group wholly consisting of, officers and directors of the Company and
their Affiliates, of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or
otherwise) of in excess of 50% of the voting securities of the Company (other than by means of conversion or exercise of Series A Preferred
Stock and the Securities issued together with the Series A Preferred Stock), (b) the Company merges into or consolidates with any other
Person, or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders of
the Company immediately prior to such transaction own less than 50% of the aggregate voting power of the Company or the successor entity
of such transaction, (c) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of its assets in one or a series of related transactions, (d) [reserved], (e) any, direct or
indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock, or (f) to the extent not covered by clauses (a) &ndash; (e) above, the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property. Notwithstanding the foregoing or anything contained herein to the contrary, in the event of a Fundamental Transaction
in which the Corporation&rsquo;s stockholders receive consideration consisting primarily of cash and/or marketable securities and in
which the Corporation ceases to be listed or quoted on a Trading Market, the Holder shall only have the right to receive the Alternate
Consideration upon any exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation (as defined in the
Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets,
consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary action, avoid or seek
to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions
of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing,
the Company (a) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the
Exercise Price then in effect, and (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant. Notwithstanding anything herein
to the contrary, if after the sixty (60) calendar day anniversary of the Issuance Date, the Holder is not permitted to exercise this
Warrant in full for any reason (other than pursuant to restrictions set forth in <U>Section 1(d)</U> hereof), the Company shall use its
best efforts to promptly remedy such failure, including, without limitation, obtaining such consents or approvals as necessary to permit
such exercise into shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>WARRANT
HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this <U>Section 6</U>, the Company shall provide
the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously
with the giving thereof to the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">7. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REISSUANCE
OF WARRANTS.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Transfer
of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with <U>Section 7(d)</U>), registered as the Holder
may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total
number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with <U>Section 7(d)</U>) to
the Holder representing the right to purchase the number of Warrant Shares not being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Lost,
Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence),
and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with <U>Section 7(d)</U>) representing the right to purchase the Warrant Shares then underlying this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Exchangeable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with <U>Section 7(d)</U>) representing in the aggregate the right to purchase the number
of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant
Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock
shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Issuance
of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase
the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to <U>Section 7(a)</U> or <U>Section
7(c)</U>, the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other
new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii)
shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have
the same rights and conditions as this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with <U>Section 9(f)</U> of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all
actions taken pursuant to this Warrant (other than the issuance of shares of Common Stock upon exercise in accordance with the terms
hereof), including in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the
foregoing, the Company will give written notice to the Holder (i) immediately upon each adjustment of the Exercise Price and the number
of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s), (ii) at least fifteen (15)
days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon
the shares of Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase
stock, warrants, securities or other property to holders of shares of Common Stock or (C) for determining rights to vote with respect
to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public
prior to or in conjunction with such notice being provided to the Holder, (iii) at least ten (10) Trading Days prior to the consummation
of any Fundamental Transaction and (iv) within one (1) Business Day of the occurrence of an Triggering Event (as defined in the Certificate
of Designations), setting forth in reasonable detail any material events with respect to such Triggering Event and any efforts by the
Company to cure such Triggering Event. To the extent that any notice provided hereunder constitutes, or contains, material, non-public
information regarding the Company or any of its Subsidiaries, the Company shall simultaneously file such notice with the SEC (as defined
in the Securities Purchase Agreement) pursuant to a Current Report on Form 8-K. If the Company or any of its Subsidiaries provides material
non-public information to the Holder that is not simultaneously filed in a Current Report on Form 8-K and the Holder has not agreed to
receive such material non-public information, the Company hereby covenants and agrees that the Holder shall not have any duty of confidentiality
to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents with respect
to, or a duty to any of the foregoing not to trade on the basis of, such material non-public information. It is expressly understood
and agreed that the time of execution specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or
challenged by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than <U>Section 1(d)</U>) may be amended and
the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company
has obtained the written consent of the Required Holders (as defined in the Securities Purchase Agreement). No waiver shall be effective
unless it is in writing and signed by an authorized representative of the waiving party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SEVERABILITY</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the
original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)
in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization
of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the
prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of
the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>GOVERNING
LAW</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Securities Purchase Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>HEADINGS</U>.
The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.
Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Initial
Closing Date (as defined below) in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a
decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual
and consequential damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder
that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided
for herein with respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be received by the
Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof).
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy
at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach,
the holder of this Warrant shall be entitled, in addition to all other available remedies, to specific performance and/or temporary,
preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the
necessity of proving actual damages and without posting a bond or other security. The Company shall provide all information and documentation
to the Holder that is requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions
of this Warrant (including, without limitation, compliance with <U>Section 2</U> hereof). The issuance of shares and certificates for
shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to the Holder or such shares for any issuance
tax or other costs in respect thereof, provided that the Company shall not be required to pay any tax which may be payable in respect
of any transfer involved in the issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">14. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PAYMENT
OF COLLECTION, ENFORCEMENT AND OTHER COSTS</U><FONT STYLE="text-transform: none">. If (a) this Warrant is placed in the hands of an attorney
for collection or enforcement or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect
amounts due under this Warrant or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy, reorganization, receivership
of the company or other proceedings affecting company creditors&rsquo; rights and involving a claim under this Warrant, then the Company
shall pay the costs incurred by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization,
receivership or other proceeding, including, without limitation, attorneys&rsquo; fees and disbursements.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TRANSFER</U>.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may otherwise be required
by the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &ldquo;<U>1933
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &ldquo;<U>1934
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &ldquo;<U>Affiliate</U>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo; of a Person means the power directly
or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of directors of such Person or direct
or cause the direction of the management and policies of such Person whether by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &ldquo;<U>Approved
Stock Plan</U>&rdquo; means any employee benefit plan which has been approved by the board of directors of the Company prior to or subsequent
to the date hereof pursuant to which shares of Common Stock and standard options to purchase Common Stock may be issued to any employee,
officer or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &ldquo;<U>Attribution
Parties</U>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder
funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised by the
Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any
of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing
and (iv) any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s
and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject
collectively the Holder and all other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &ldquo;<U>Bloomberg</U>&rdquo;
means Bloomberg, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &ldquo;<U>Certificate
of Designations</U>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &ldquo;<U>Closing
Sale Price</U>&rdquo; means, for any security as of any date, the last closing trade price for such security on the Principal Market,
as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing
trade price, then the last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Principal
Market is not the principal securities exchange or trading market for such security, the last trade price of such security on the principal
securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing does not
apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported
by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any market makers
for such security as reported by OTCPink. If the Closing Sale Price cannot be calculated for a security on a particular date on any of
the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the
Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination
or other similar transaction during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &ldquo;<U>Common
Stock</U>&rdquo; means (i) the Company&rsquo;s shares of common stock, $0.01 par value per share, and (ii) any capital stock into which
such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &ldquo;<U>Common
Stock Equivalents</U>&rdquo; shall have the meaning set forth in the Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &ldquo;<U>Eligible
Market</U>&rdquo; means The New York Stock Exchange, the NYSE MKT, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq
Capital Market or the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &ldquo;<U>Excluded
Securities</U>&rdquo; has the meaning given such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &ldquo;<U>Expiration
Date</U>&rdquo; means the date that is the 60<SUP>th</SUP> month anniversary of the Initial Exercisability Date or, if such date falls
on a day other than a Trading Day or on which trading does not take place on the Principal Market (a &ldquo;<U>Holiday</U>&rdquo;), the
next date that is not a Holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &ldquo;<U>Final
Closing Date</U>&rdquo; has the meaning given such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &ldquo;<U>Group</U>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &ldquo;<U>Initial
Closing Date</U>&rdquo; has the meaning given such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) &ldquo;<U>Options</U>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) &ldquo;<U>Parent
Entity</U>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or
equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the
Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &ldquo;<U>Person</U>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &ldquo;<U>Preferred
Shares</U>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &ldquo;<U>Principal
Market</U>&rdquo; means NASDAQ.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<U>SEC</U>&rdquo; means the United States Securities and Exchange Commission or the successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &ldquo;<U>Spin-Off</U>&rdquo;
has the meaning ascribed to such term in the Securities Purchase Agreement.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) &ldquo;<U>Spin-Off
Date</U>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) <B>&ldquo;</B><U>Subject
Entity</U>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) &ldquo;<U>Successor
Entity</U>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &ldquo;<U>Trading
Day</U>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any
day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for
the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that
&ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less
than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market
(or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the
hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or (y)
with respect to all determinations other than price or trading volume determinations relating to the Common Stock, any day on which The
New York Stock Exchange (or any successor thereto) is open for trading of securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
<I>signature page follows</I> **</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Acanna
    Therapeutics, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXERCISE
NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">Acanna
Therapeutics, Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. The
undersigned hereby elects to purchase ________ Warrant Shares of Acanna Therapeutics, Inc., a Delaware Corporation (the &ldquo;Company&rdquo;),
pursuant to the terms of the attached Common Stock Purchase Warrant (only if exercised in full) (the &ldquo;Warrant&rdquo;), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. Capitalized terms used herein and
not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Payment
of Exercise Price. The holder shall pay the aggregate Exercise Price in the sum of $___________________ to the Company in accordance
with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Delivery
of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, __________ shares of Common
Stock in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; Check
here if requesting delivery as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    to:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows: </FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
    Participant:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<U>&nbsp;</U>_____________ __, _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Registered Holder</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    ID: __________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
    ________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
    Address: ___________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACKNOWLEDGMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares of Common
Stock in accordance with the Transfer Agent Instructions dated _________, 202_, from the Company and acknowledged and agreed to by _______________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Acanna
    Therapeutics, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enveric
Biosciences Announces Plans to Spin-off and Dividend its Cannabinoid Pipeline to Shareholders </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
proposed spin-off would create two separate and distinct biotechnology companies, one developing next-generation psychedelic-inspired
treatments and the other developing innovative cannabinoid treatments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NAPLES,
FL, May 11, 2022</B> &ndash; <B><U>Enveric Biosciences</U></B> (NASDAQ: ENVB) (&ldquo;Enveric&rdquo; or the &ldquo;Company&rdquo;), a
neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced
plans to transfer and spin-off its cannabinoid clinical development pipeline assets to a wholly-owned subsidiary, Acanna Therapeutics
Inc. (&ldquo;Acanna&rdquo;), by way of dividend to Enveric shareholders. The spin-off transaction will be subject to various conditions,
including Acanna meeting the qualifications for listing on The Nasdaq Stock Market, and if successful, would result in two standalone
public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Joseph Tucker, CEO of Enveric Biosciences, commented, &ldquo;In these challenging markets, the Board and Management team have spent considerable
time evaluating the best way to create additional value for all stakeholders &ndash; patients, shareholders, and employees. We believe
it would be in the best interest of our shareholders to spin-off 100% equity ownership of our cannabinoid clinical development pipeline.
Upon completion of the proposed transaction, each resulting public company would be able to focus all its resources on the development
of its respective pipeline assets, enabling, we anticipate, greater opportunity for product development success.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acanna
has secured an initial $1MM from an investor in a Series A Convertible Preferred Stock and Warrant financing. Under the terms of the
investment, Acanna will, subject to certain other conditions, receive an additional $4MM upon completion of the spin-off into an independent,
separately traded public company listed on The Nasdaq Stock Market. Following the spin-off and the investment of an aggregate of $5MM,
that investor is expected to hold 25% of Acanna and warrants to acquire additional shares. Palladium Capital Group acted as a financial
advisor to Enveric. Please see the Current Report on Form 8-K filed by Enveric on May 11, 2022, for further details.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Tucker continued, &ldquo;For Enveric and Acanna, this spin-off transaction would allow each company to commit 100% of its efforts and
capabilities towards developing its respective drug candidate portfolio. For Enveric, going forward, we intend to focus on mental health.
We believe that Enveric&rsquo;s achievements in the last year, including preparations for a clinical trial, positive preclinical data,
and ongoing expansion of our drug candidate portfolio, the Psybrary&trade;, position us well for the future.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strategic
Rationale for Spinoff</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that spinning off the cannabinoid assets will allow Enveric and Acanna to maximize long-term value for all stakeholders.
Following the proposed transaction, both Enveric and Acanna intend to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
    separate, focused management teams with the knowledge and skills to deploy appropriate strategies and meet the unique requirements
    for each company&rsquo;s operations.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate
    capital more efficiently and strategically to develop their respective assets further.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    unique investment characteristics of interest to the capital markets. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Enveric Biosciences </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Enveric
Biosciences, Inc.</U> (NASDAQ: ENVB) is a neuroscience-focused pharmaceutical company developing next-generation, psychedelic-inspired
mental health medicines. Enveric&rsquo;s robust pipeline supports drug development from the clinic to commercialization aimed to help
millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD, and more. For additional
information, please visit <U>www.enveric.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These
statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking
statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology
such as &ldquo;plans,&rdquo;&ldquo; expects&rdquo; or &ldquo;does not expect,&rdquo; &ldquo;proposed,&rdquo; &ldquo;is expected,&rdquo;
&ldquo;budgets,&rdquo; &ldquo;scheduled,&rdquo; &ldquo;estimates,&rdquo; &ldquo;forecasts,&rdquo; &ldquo;intends,&rdquo; &ldquo;anticipates&rdquo;
or &ldquo;does not anticipate,&rdquo; or &ldquo;believes,&rdquo; or variations of such words and phrases, or by the use of words or phrases
which state that certain actions, events or results may, could, would, or might occur or be achieved. Forward-looking statements consist
of not purely historical statements, including any statements regarding beliefs, plans, expectations, or intentions regarding the future.
Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available
to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain
factors, including, but not limited to, the ability of the company to successfully spin-off its cannabinoid assets; the ability to achieve
the value creation contemplated by technical developments; the impact of the novel coronavirus (COVID-19) on Enveric&rsquo;s ongoing
and planned clinical trials; the geographic, social and economic impact of COVID-19 on Enveric&rsquo;s ability to conduct its business
and raise capital in the future when needed; delays in planned clinical trials; the ability to establish that potential products are
efficacious or safe in preclinical or clinical trials; the ability to establish or maintain collaborations on the development of therapeutic
candidates; the ability to obtain appropriate or necessary governmental approvals to market potential products; the ability to obtain
future funding for developmental products and working capital and to obtain such funding on commercially reasonable terms; Enveric&rsquo;s
ability to manufacture product candidates on a commercial scale or in collaborations with third parties; changes in the size and nature
of competitors; the ability to retain key executives and scientists; and the ability to secure and enforce legal rights related to Enveric&rsquo;s
products, including patent protection. A discussion of these and other factors, including risks and uncertainties with respect to Enveric,
is set forth in Enveric&rsquo;s filings with the Securities and Exchange Commission (SEC), including the Company&rsquo;s Annual Report
on Form 10-K and its Quarterly Reports on Form 10-Q. Enveric disclaims any intention or obligation to revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valter
Pinto / Allison Soss</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KCSA
Strategic Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212.896.1254
/ 212.896.1267</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>valter@kcsa.com</U> / <U>asoss@kcsa.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalie
Dolphin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enveric
Biosciences Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">416.706.6364</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ndolphin@enveric.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>envb-20220505.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaCWbP9z5Z8yekhvWB3bZmqTyMj/T2WnieTWJvG4b0C -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:ENVB="http://enveric.com/20220505" elementFormDefault="qualified" targetNamespace="http://enveric.com/20220505">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://enveric.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="envb-20220505_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="envb-20220505_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>envb-20220505_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>envb-20220505_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://enveric.com/role/Cover" xlink:href="envb-20220505.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://enveric.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139770513572584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Enveric
Biosciences, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000890821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4484725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4851
Tamiami Trail N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Naples<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">34103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(239)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">302-1707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value
    $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ENVB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="envb-20220505.xsd" xlink:type="simple"/>
    <context id="From2022-05-05to2022-05-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000890821</identifier>
        </entity>
        <period>
            <startDate>2022-05-05</startDate>
            <endDate>2022-05-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-05-05to2022-05-05">0000890821</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-05-05to2022-05-05">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-05-05to2022-05-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-05-05to2022-05-05">2022-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-05-05to2022-05-05">Enveric Biosciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-05-05to2022-05-05">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-05-05to2022-05-05">001-38286</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-05-05to2022-05-05">95-4484725</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-05-05to2022-05-05">4851 Tamiami Trail N</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-05-05to2022-05-05">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-05-05to2022-05-05">Naples</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-05-05to2022-05-05">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-05-05to2022-05-05">34103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-05-05to2022-05-05">(239)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-05-05to2022-05-05">302-1707</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-05-05to2022-05-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-05-05to2022-05-05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-05-05to2022-05-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-05-05to2022-05-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-05-05to2022-05-05">Common stock, par value     $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-05to2022-05-05">ENVB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-05to2022-05-05">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-05-05to2022-05-05">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&;P.]@:XOI+2O WL9CC_+6/P'U!+ P04    " #8;:M4GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " #8;:M4!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -AMJU3?"ZSC[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( -AMJU297)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ V&VK5/%!OHY*!   UQ   !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( -AMJU2?H!OPL0(  .(,   -              "  8X,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ V&VK5)>*NQS     $P(   L
M     ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @ V&VK5*K$(A8S 0
M(@(   \              ( !4Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( -AMJU0D'INBK0   /@!   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -AMJU1ED'F2&0$  ,\#
M   3              "  9@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  .(3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://enveric.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>envb-20220505.xsd</File>
    <File>envb-20220505_lab.xml</File>
    <File>envb-20220505_pre.xml</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex10-3.htm</File>
    <File>ex10-4.htm</File>
    <File>ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "envb-20220505_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "envb-20220505_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "envb-20220505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ENVB",
   "nsuri": "http://enveric.com/20220505",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-05-05to2022-05-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://enveric.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-05-05to2022-05-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://enveric.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-22-012822-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-012822-xbrl.zip
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M)^*&H4J*2JVOE;):ABU%TM)=06"UI:J_E1A$Q=L<&8U J[X]-O^7N^A1&"/
M9 >[S'4W8#.I=P5-31 8=!@S3E8J*5):7Y,=#EW8NG]0L/8V*%CW# K6(0X*
MUD,'!6NO@P*UZW*9$M%&W:[29(V!11,[U:[!Z+"L,V*1!H4+[ ]L.^H0=(CQ
ML=IFL>R:?)4 WQ0>KL0'2TD!G;/U-KMLU@MNVD1!<-+ES%ARLUP(KR%&4NV#
MC6V<Y"0N#5TE%-,HP6F]=*/MZGE_B#-B!IJOX>G1A\'1,),&4F686F.Q#CPL
MP^GCLGOY$,<O)$U_HNR5+@C.&"5Q>;W%=G>I6^_VJ9L>V^T';P!Q$$@-<0@\
M?B.#QD\R"JFPZFJ9-YJ^L71+<\R+.>S<UD(!.K?T #;;U&BB@&BQ.P,HJ<6H
M5/N;%%ZN7E$/O,IW)H&%A.2.IXAWFM9FBENU 7'3:1":-UZM.7(8+Y=1'J=S
MYD2^ZR)Y(5]PCBM_8)DAN>L)G%VF]9F;-FU &'4:!.=JUC%RN1JLN/*Z; V?
MB>'7FG4\?:ZIW"]>8U@TUZ^I)0$A8O/5L8H-1TKKC8?%!J?IYVV64)+!G9*F
M<LN#U6*;AY8D(!YLO@ >"BE26F\\7&X(7XON[D?.7O/':@U9L'R VBT?G9;;
MG%BE ?'2Y0_@1H6@,D8M^^L/H-UA ?1R!4BXM!:I8W1 LQHWABXD:"!S!C$I
MB>3UF!N6HR5#7S."\D>"+JO7ZC57KB_S\?F6E"B2$R[*T3J-,;=AU"5V_L84
MT+#QWA1#&01,O?;@=ZC4$4B%>"#G5K#,F^=XA9%Y3C;@3(K^$%<4#36O6.K3
M!T'40),Z5T58^\2["$0RTO>J2LT%^>%A7TOD>+1L,:@-EAN*(#@!;4%#Y>;[
M#?RMY[==I4ETE3(,7X5I:1ROXF?:TQ;P.P@"HL!T!2W;5PA1H?3&P&=,G_CV
M.8_V=YQ%A,BGM;*ZY>J[1C<PVBTW;RI2FZA!H0&Q]A:_ (6'+% CCP^-WLOW
M!3_Y,+I<88Y%3XM'+ [B[3;/9(\JS,%7S#N#'-^*&%  [89$1T1 ^ VP"=V<
M*")1$?H!E<&H$>WQO"T[K$Y(XL_[>_) N)S3L"2[_+/8V5/'F<> 6-=G=8.+
MHY_D]08& >);W4*G@!EJ9H!6\CFS*@OTJ\P$%;G8WM/>W'0M/HG-:I/XM<(9
M$5O^"U!+ P04    " #8;:M4L;-9YU0'  "_6   %0   &5N=F(M,C R,C U
M,#5?<')E+GAM;,V<WW/B-A#'WSO3_\&EST" 2]ODDMXD7+AA+I>D@;MK^W(C
M; &:R!*5Y #_?24;<_RPY,W+;?*0$'LE[?>S0O9:DB_>K5(>/5.EF127C4[K
MI!%1$<N$B=EEX_.H>37J#X>-2!LB$L*EH)<-(1OO_OSYI\C^7/S2;$8#1GER
M'KV7<7,HIO)M=$=2>AY]H((J8J1Z&WTA/'-'Y(!QJJ*^3!><&FI/% V?1Z>M
M3F\2-9N >K]0D4CU^7&XK7=NS$*?M]O+Y;(EY#-92O6D6[%,816.##&9WM9V
MLCK9_!3%+S@33^?NUX1H&EE>0I^O-+MLN'8WS2Y[+:EF[>[)2:?]]Z?;43RG
M*6DRX;C%M%&6<K54E>N<G9VU\[.EZ9'E:J)XV4:O7;JSK=F>90'['4\T.]>Y
M>[<R)B8/>VTSD=?"_=<LS9KN4+/3;?8ZK95.&B7\G*"2G#[2:>3^VNAM6Z7"
M=C\6NWBUW;EV7]H#UM&\U%S1Z67#VDQLY=WNR>G)J:OZUSTCLU[8?JF9ZU:-
MJ+W7[$)1387)E=[: WM%Z,K8WD23LB+7/M QPXRSW7253M1T_2I+;5/V8V&Y
M\:/TA,MXKW'N^,L#I65?SBEK&K=F\KF=4&9I=SO_O7$?F\7''(/]]UO>V-5$
M&T5B4];&R83RO(UOUN; I/V#/"N)C&VMU8[M6QSZM1N[*Q5'4B546>9E743%
M>Q$[[IX;B_:"*%M1,YXSO@WV5,G41VA#0WH<W85EF_AQ1*^L#XGS8\#)K!KI
M@0F0:0<#:J4:3*KOJ8X56S@V-7#W+(&,NZB,*[0AH"Z_1X]TQIS/SAUW :;N
M8'B,\!0!PN]ACAI!M8A1N!(B(_R1+J2J@;]O"63^!I-YE39$U']E1!FJ^!I"
M^\@8"/P4$[A'(2+SL2)",\<( OW8&DC]-]0;$H]&1.RC.>7<)7E$@'I[E3T0
M_>^8Z/TZ7PG\FV=WW;>7&SC_G2+ $/SQ6D)PI!8Q"@\V<Y2)O=0K /\C8R#Y
M,TSR'H7HS&]$ B6^-07G2/C #^0AXAXP'1->>#6PQW08>84Y%#M*;EHK$QW]
M/Y0H,/@=8RAVE'2U1B("]'ZFU)Y#P1'&;PW%CI*HUHE$X'XC##-K-V-PEZ63
M[P]>]WD?6T$YHR2G/E%H?,LG$\*XR9 0XT-+*&>4G#0D#HUUWVI2A ]%0E<?
MZ3H$^\@42ALE%PW*0\/]H%A*U'K$XOH!Y-@6"APE PT+1",^)JMA8I6Q*2NF
M%NO!>XM ^:.DGR"Y:&$8BEBJA=QYW-R7F?UNKOLR"0[Q-06A(4')2U\@'2TP
M5TEBD>G-GULF:"<4CDIS\%P37A ",E\1^N[+T'?AZ%'RU5J9KPA][V7H>W#T
M*#EKK4QL]'W[\5Z-Y=(SJ^TUAF)'R5EK)&)#SZ\^]^I!R6=6K+RJ(W]4 HH?
M,94-B\6.P>;B#^GUI264.6):6RT.F_6#U(;P?]FB[BZSVA[*'3'!#0G%>#!9
MQ-\]Y/ M5SHP@3)&R6DKY6!@=9%6E/B[\;X%%"I*HEHE!H'IK71S*',I@L]R
MCZV@;%$R3I\HC('8K6/6WF%@YS1XM1S*,'LH P'E5\6,]:(OTS03F^<ZGADV
MCRD4,4J:&)2'@'LD.8N986+VR=Y!*D9X->LJ.RAHE*30+PR!\H.B+N+4WIKG
M:\;<I@=U/YWZ1N*0/90Z2DY8+Q2?_E#KC*J7QJ"B%#02*.DA5#3&F$/CS Z#
MZTYW,G:[>#PCSI$5E#=*:N@3A<#W3HX5<3L(1^MT(KE_JTJE(90R2B(8D(8
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MV,2 Z-<\L%,G&,!UTP]H;U0+6_(+AL5R0D%M_&AHQ,#GT[SB^/^0C*/!_C
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M.#R9J4N,@B%.!XL'[MX7T)MDG'F32,*_[)WH]QP1AS-<0UGMD/0FJDZ((K,
MZ%FD[?/@3-/0[HS:9F>_][/:G2.Q.\=D=^Y%HPJ3DS.7NNMDI=SP[2Z:RNLM
M)B[GL#S7CC]6!)Y*T13WC#NQ."!TTBT13^D++*.!E#$RCX53CL/;'+48>RZ$
M)CVWG: #=P6W/"5O2&SS&]U7[Q)L\Z>+4O,>G@..'19;-<&G@"+,M#F8QPB
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M_5XCJ48&=D)A')>4]HA=D_<@\U-I,S@*M2[SK+H0,!;"E,GNG/",2BXR@K^
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M(B@SW E!D3;D'(.O::J2A?:<<8*)$\"(Z1TPKU"VG&!\@[XS)[D@ ;O4E]/
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M$MYU_C3+?J8#;1;.Q8WSAS&.KBD':<HP2]25C6_ONJO)LS/C'JY<J6?NCE'
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M?%*"4,HPPL;HIW*!?OSD'JANNB$C\?4N(W&W&8FO=QF)G;7586VAN;41.]N
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MS#/ ?F[@ :QA]9,9_$J@JOI=A#V1#$<]\5M19K63NGBA=1)"7^@&W\%72$!
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M,(E!P7?B55&\YZ-[DF+L8I-:>9^F*ZIA1$9^^DY!W=/@*ZP^F(TZ]E[%?(V
M/VJA6>)-0??!4%U.4LI84#*&:*G8ST440K/S*N4NJBJ5EIP?12K:$93Y<30Z
MWIW!+V 2@Q6?P4-7>OPZJY"OP=5@1&,DN=ET)JE:(ZC1\(G6.(R>&LI3R[,A
M_$_<=;O[Y:;,EJ,_!\R^ME]P59C4!KM>$O@1IN8AEY8H96/3,QL.<B*=H@E)
MS[QNX.4V7]_O?<3[=^?Y"YC$X%]*B2SA(:5_;$) CY.2HX?:L7PME0@F1CA!
M@SN=([)X8U/<J1QES6&OP*T[FL^Y:-P_?6L?"4H;+3''NO61%-["$[NXEFS_
M[LA] 9,8E&+:GNU'8WAOQD2%PCKJ5&0'GVBG]1:D25P2P+DTR86VV3#F7& G
MHQF) !A*ND72OXT4^CR5CI(6F&GZ,GCH+Q,8XB=>IRLXC6!C7T=G)58DZ 1&
MZ[I8DLEKDCEG^IIC)I;FTE=7;A>^CUU#'1EWZ#$1;NG,1\_9'?0_?1+RBZL4
M"T:^P[Z7RV0!IQ^#$#JQNV/I?_<#2#SF/3\Q.'"^5.\<I=>,92:UT.OW:F(Y
M?3QD+D!;S!'0>W5YE12B=VT[IWQ,78X]^#G]U_H2O#[R#6OJCTO)'D;5()Z(
M$KF1*YQ[!WZ;LC;>@+#8,&#+1T;A$T.+F P=>Z;JC4DFM%7DZ$:N#:40P8<4
ML*%_^C,UW^#$VC&Q]@35\TQ0645/GKYP1%Y^>M&@\LU4DQF>26G<2&*.LJ98
MMX I"$R0..KZ['TZC-ETXTW-$#6'4>/2H?XOB\5Z:;EQO!S!IQ,,WN+-A B2
MA(B95;_'TZ*6BW6$2/,Z^NO3QX_CQ_ ?-2'1AO2DRV,B@D7!K,1@[>)$@[E:
MIE2%OVU$_5Y[H>7EDZ$]G4'373(1'&A/^&E-<E*%NO)&RP=,1L>1T>K4^[V_
MOHB66$S-R:@Z+/3L.-Y\V_0@A = ($(>'U0-W?52VM6)00\$:!\:++:TT57N
MP/KXP\X\L(D^"<_U!H+M[MRS."LXH16&*FN)W< 568 <XA06*!^*JZXKBS>
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M"SL(+UQ'G,&A6?Z80$/4$6? !_5[82N=F^,,H8;^F#!#X'ZTPPRN(=\#B3/
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M6*J?ZR@9:N!*^KUOA69]0ZC0MK_ 9%E'"R0G;)3@/SHLFKOI'N[#IB[W6),
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M7+6.XK1 =AE<0^Q":M@8.XY]1WP(5JO?,Q32Y C)7;/MB;S$W62Z;CR2IGO
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M,>JV860Z%QKV?UIDD6+7&VMNLYD/%_O)< S!UG$N6<T2$*S>"O8L9%;S%_N
M1DC$!+6:4_-4*13$*.-P#</12/:2%,<N4ZZ)J+2G2^N74^OP,LR [)B6<^EN
MB%I"HG8"$A*50)@5S,[4!*(57[.,>_A>Q@]=L)$WE[M->09/"!UK4NR)GD-
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M8'D=FF! ZDY/\T!MR)Z3J>6&R-3.+.4/?GEX&=J#P.2"0S0E$-NE!A>,6[O
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M#^SC_V(#-EQHUG'^O UP&:OO&H%CAH7#RI%DW N-PI^N!HBIIJ6?)TBE$WC
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MQJ?#7FC2B.GK*^OI(;6H,[EI3,Y$\?,I\7Q8Y2RD,W<3$=ASXOADZ' GC?I
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M7%'N(WV>'HL!*;\PI\VS0O_5DP,P[_*T2%0U'B7H;;>%9KH0B=[!0TSWHE?
MNL2/9AQ)J.5>EOT$P/4N*&\WW;.$ZW)3]+=@<RHV+S K9GF;F)#H^O?JRQ)X
M$4QC\$W+O*VW>\&ZE,_@]>U$W\<CZP30P7;CC!70+MYSC.^R5Y[O*59S\8[
MI: =&9@BOT#?J<Z,)X?3D$^?\\*E_JFP*9R! C3_DO;/53M/YQM.E\*_+S&[
M/JUF6<W0#OT-;0O]0,+9G\[LX&(T+@>E=]6V]B($(<#DI-,O=: $]P?N!*G
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M4:V3!>>G(OBLL\,/,;6.^$,TQ!O&HT'F@':J[&"/BN=4T)2T,P]";VC_*"5
M1P[\!72V;#SB/6-^BS<+C 1T12BNTD#RBBVCU!<.+S]B8HN70DM?8P8$J0,Y
M Q:>%6DT.9A&+UNP[9'NCM6*).X\ ]:"P^8K20./#.60NNR8U:"JY-V<\M]%
M6W )"U8#8*OBWR%9G/)P0S$#!D-7U#BRF]"HM-(2 N5Q58V@@(I#.N]:#2-#
M46S, D5+LYKI9EX&:A"5'M!CM(]T/Z\](#W7=SI,KH:G!53J@5H6"\?SB28%
M*]0)%I!T"@Q953/X2<;6B5E8&?ZXR>3L,[IM,D]]IL- ]&MU),D2<IB]CE^6
M.G*)-B:C4@=XW\:MDB<=HR^H[S''JUD9V53_UY&8)VS<V]"M,=6=>T4GU?=G
M.'HF$%B. 5-UP;E;Y6!)*X'*:;Q/PJ1"&K@NN4($+ZG6%/ !;WI2[..YH[LJ
M2,!B=TM[2 <B*4YR&Y_&/^$F5H1 0MYC^?L6VJ4.-(LBQDG!&$C"U ^P-K$^
M*]$WA*IKLYD#KL*W="*H:+179B99E]3#$Z"D'UVU:WP0UK%=9Q\I ;D"(3%Y
M<E W4W)*"(=T_!"HA:RM2;.8);VYNKO&64C+)2G9N:D)V[Z<E1-"&G]KI>2M
MI)X-VK342>B$75($.*P79^A;-(@FDC4K(9!-S@:72W:3(QG?5MMKZVJO/7_:
M5KS,BW>X7',+&U<'LG26EA5A\\Y>>(R.W #O,9WSX(EZ<#!14]07>A;BFU(P
M&;)"78#QT=!IB^D^8,6MT^6T&N=$1Y"+K+0$[Z2"\AM+C8GHPDK0R AW>5FI
MY54?H(<H^**F.'33]P$9[P.]@KS)CE<Q9)AWY\XUN'53Z73];+'D!%BQQ8$1
M%45:.4HR23=D%00F3STK,.[1K*Q%1V0FRLD:-;BCJ1<ITINJY'2JBOW? _/7
MN(O:KR/AKJG(,?&H)JFP&@8#=1'YS&PS]*$E:;B^?VO?B+\R%A$+]2'%T&UQ
M*4E%[5)V%W;'+I=+6+/*8&55Y9),[4ODD1T_LE/(?<]B)[\C_^71+O_E5O-?
M'NWR7[ZP>.9GN8F/!?+*21=\;Y!L3?4&,E#'\[)"H_W2,5]!00;FIK%F;7 )
M[/H'B,"*;CQ4XY@'LG@,(QQ2'5F!T:$L:#L:D"7,,$ -1&KL$P/%XJ'6\C,9
MAMU@3O@Z$!-*,&"<\"KY B6[X5A2;+APTL_T6" (G212EDLVPAVW"$VBI\O'
M! Z<+GA+@F9?+Q$='1V4_\@(ZZ X-#&E4(I"3&[5H)VA4UCPF\G!?J?,IH\R
M+$ ?+H!QSX5IOND6I>R!AJ@=A-Y#?8</:>$F==57;[MEH @-(KD?6TVK;RMR
M]H6R+^2B5Z\R<GUA8V]X0V$:2)$K$WP@10-)8']NW!/#\^\6[G)1)I4/>9:J
M3B,*VD*K]0 0[L5V5R0@&CQK]O1);A;JBHS2C5NB;6#Q[[%FWYD%9SET%V85
M4,G[H@B62ZOHD\#HBWD)A@G=:+O!%R6\T7XRA;$YY:;YV#Y=\K+)7Y2SH5 -
MBV D%5U@72_^UU8ZA]R'O0&UI>,<V0XX\"ZL\)L73T@"OFL;8&5+4;9_N1\-
MANYGWI6:=E42,LG7ZR0=,-[*+7#__5J*!ZOO-(T;U%*>1=QU8.K@LP53:A4!
MXE8,AM=K,[,>2'(\XAY(%S!(64C@R4SIDX?3\5*9#NE4!)ZKO4XZU<&\ H:]
M+$O,@%1P2K''ZITT4\HPP5JY7O>HMHG>XQ=^_2NFNFB8+P'4XH*74M>]=I-2
M;:T,D$A.W4"4FQ[22<TQM83K]09/6Z <(<IB=32#$,0R^F*I%J?J5?[B>LW&
M]W4!7^L+R?ZN*B@Q) /]I/<S\&+L>B0!)P[[>>K=/>,=]Y,A7OA0"SMLA3N2
M%HWRYW3>@WGK.:C)8TCV79U2P&LX*]CU93L>RR<@-"4;8>!=QDC9;&@0.^DP
MC6&.0R$WBCNM])=%I\&AQ [J$I%- ZPQ$ GL0T/NX ?NX*)($WJY&H]<^2;D
MTZ&PV#.'C7$K.*"29!FN>,& YN'4BT*A7H85WZQ_P+7 XEK!@48'*R:P9*R%
MZ298AA!CRD_MCJ95 .OKYT@RI5R8!N#X+VJ=H3Z M*8HFGE>W$^8#$SW/'C!
M&<.W ?N:DRCI(OCAB2>"F8O!T:-I9_*$]XDH!_0]E;=H5Y@NFEF ?G2I+KGN
M*T\3_)O.1%F9[8'/V $&?[& !QS5+>=S3/E)BQG<]$H1-+3)#:S<WL3PJ0LZ
M*S,IL.T6IK"IIBZQ)D$G:4NZ!<8-5<7<IH/K3"54.O-GVQCHCE?<@45QK[8S
M)P?:$W"SJ=O4DFQ ,=ETB:#*TY#O9EWX]XD3/\4K"]J^FJ5D_Z _F2R^0B#5
MHLG#_6E$U146WXQ2-Y?AS-7Y$*L;JA6B&*$K]G2G,TRTA:\FC^7]'6M WJ0K
M/?2^#!E=GJW[QUL#7]@U61^%?+R+0MYJ%/+Q+@KY)7+YSXL;>-Z-NG'H2*T,
MP_2=)1:1VJHYGQA1,*W!NDP0^TXU7P?6\UU?%*;#]DA'Q^RTR"0CPA'H^!<E
MRBBHDI)+9,)@JVZJ4E&WBP4W9TU9I=B@CH]'HH^;1+?8U WE3MH_<52+PJ6]
MK[6+F4Z%Z&Z,C^T5&Z<CG9Z;+[O+X12]3AZ26F+R497MR/MN+&J23J/#AKU%
M(=666N5JOHAZKF6&&U7<6-J)!)1.1I.HTNNL;+&'O4G(Q:[LV+&1*R!]F'T<
MRH>S<Z>ST<7$!:^]<3D1<#[/$G6=L;V)31JF@O=0Z%"VKLHD QP,X4N%=\3H
MXLZ$?#FRNP9?;"3S>PK2'AIXL@Z<L.@!%.0#"Q%C+KJ<YJA<7#AYM&XB-:<W
M!0KNW(P>'L6F-,'P!!C'O)UP7&M^8X(4>L& -TR ]3+/N'T)_$,'@O2_9W9B
MF" T\X"_G;[U&MO'9BA-J5X*GJ 2E%E.0(6T(W0KMJCN8Y3U2P)_J'H9#CIW
MI[.[F"?.":K!%GC2B,-L_GBD@=%1SG#,C7\B16O_JZUG!%W>P[7[/A[]P1L?
M;;WOF--&&U\O,+_I5C?>650TM.^Z."+9&X\.T>%GT?[628COO21R>)%;UM''
MQ*!XN/G>@Y>H_:OIS!EF=,JRC//]&$2'LPW=>6K?7FB&%&.OHZ0U;F3I"<_@
M)8%]K=UR=.I=@\-S\854@<OW;MU9;QR3WL03Q<PPJUMQO8E4:0O"-2[Q/J0'
MW2L1\S<2,6_*8I95LW:!9Z138,>CKD,.B>5BY0#6D@:"2GL=SN?0"6I4DJF
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M #Z-7F,6T%?F./"<!%WU)VC;WV'K^]N7;X__A63][4_G/[]^\?\!4$L#!!0
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M132Q0#) S4[AID?=!"LR7:@9ZKW'1U<C/;LF7/K1;$1!?E(9Z?0#0EE:WXY
MN!Q.L//6""6(X1:W>JT:.3HIYWV"SS<.I:J7+V&9\I!MDU?IM'0S"&313)0"
M>8&!FJQ"4SP,M0^_ #XY4=-TJ>KK;8HO0&((BM0^@*/FK;<[CN^!>8(]QE^%
M_]GG2]G)T7Q$W\JMDK>#1/ (KPJ-D428/HS+%>2K.,)*@PB1*PE]@9=WYMB
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MD&INO@YL@?M,GJ:9%X5]ZEGFYDRRMS2;L A!#8JP 7^ G*C=  1?X_F"6B-
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MO##C?U%3[5;1N8JMJOAN/4]/[[7JQV_H>#M:</L7-.C+;[2RL#IRV^?=H:R
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MBYFU%!1>KZ1N8685W@LTT LKB\<N1))-IUT$SIMA10UP_)2\$QL<&^SN8@^
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MP0A@$A2$Y>M#;+16]%BI*WQ55FM%8%P:4B%6F827)(_1HOQ]&9>K7K"!C8=
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M.+(>XOAR'0BME]@HT=:B%O1$!6"5X"JQ8@$3@2X1;KDT*3QZ 7 TFRD)R-B
MRN!;U!J"IB74(BG$7<I!F36D,>F[NSE[ %=CSQO^J=7=:M$J6,;I(+Q5N>.Z
MTC&@565+1*:*AU0<O3Z#FPJ#(Z HO/A7NO6(%&%VRD2EI71JNIS B]:%CK"\
M:U+CB:Y'[ZC=<[@BK!+0;Q8:[#<NU S\.K03_)C67<%EMHKDK%IB3K\%+6-E
MEQ77D0[G=?EYL&Z--[F#"&O:52M4J,V?'DL&*R_82ISK&8ZN<M:0@^5AT@"$
MX:3#RJ0O70@P.W5 8<?0*Y.5RA-0^7R(YK+R476\(%W=H=64DWDW!=@)Q\B0
MR?8^7:98I83Z!M28"3I]H4&[P!DWJ5L]IT#+J3JN:N7K=!YX3<3GH@I+LYFE
M1V_D8017ELM3M''$7BXT=\$_;>"KQEPG)P%U/= ]O&"9E(6;-7(%4X=U?KO
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M5W),X%VM[PU:K?NO.C>=2#FN1>WN^U?!DR]?WG3G+LL7#MN%%+83],8##(D
M]V7&. +EKZSM#UJ72NNZJYS:IN>J.4^!LH!X_U1&<I/VL1ZYP"S[*3H8%%H
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M4<(=M;M@_'->5)=\"U.=D* 0M:W9,^2MGG]/.=3]L>E^2^ZURS2\#8H11*W
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M"F4-5/X5PZLGF/Q0Q:53JQ.TI@6%XO%9L#05!(T^)>E34C32*E=TY:IIN#4
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M.:[Z(S&-<^,B4#6%5!4K3W!BCY1/J7%CA8YCRJ-(%:Q(0U73I*8F:Y9WJ]M
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MD%DPQBR**+.$_B3105Q[2CFM2TKB8.P!ZDI,B(K9G,M]D3CQ7]-?S ,?:Q#
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MJ_$22'O?PKBMXAB<XP1/!YE[,S":AQ0F#^7/1O +WN+'JX=2P$^B:O^WNC4
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M:0&_@)>J8;7&BWY6T)L8H6JD1 IX3WT%L K0FI/L-7,J.2Q,Q\B"!V M_8*
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MX>X;'!MVDJ>[^[UO=_9[^]_L/]TXXK/8Z\\/"ZV*3WN(!T>=#T]4[!V*E[Z
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M%;8R<K\Q:L)/@G\.?.Y;K'J05S_A:9_YE. 0.78;\+M7F9IC^\SV<Y<C%Q;
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M4$L! A0#%     @ V&VK5&V'L-W_"@  ;(<  !4              ( !:0,
M &5N=F(M,C R,C U,#5?;&%B+GAM;%!+ 0(4 Q0    ( -AMJU2QLUGG5 <
M +]8   5              "  9L.  !E;G9B+3(P,C(P-3 U7W!R92YX;6Q0
M2P$"% ,4    " #8;:M4FZE7/ J%  !*1 , "@              @ $B%@
M97@Q,"TQ+FAT;5!+ 0(4 Q0    ( -AMJU3TE%#XXTD  %"Y 0 *
M      "  52;  !E>#$P+3(N:'1M4$L! A0#%     @ V&VK5-/%]*>76@
M2]D"  H              ( !7^4  &5X,3 M,RYH=&U02P$"% ,4    " #8
M;:M4W'%:MCE4  !,)0( "@              @ $>0 $ 97@Q,"TT+FAT;5!+
M 0(4 Q0    ( -AMJU3]I[$SX@X  -Q%   *              "  7^4 0!E
M>#DY+3$N:'1M4$L! A0#%     @ V&VK5,_Z-!]Z'   "L@   L
K     ( !B:,! &9O<FTX+6LN:'1M4$L%!@     )  D %@(  "S  0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
